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Abstract
The usefulness of Raman spectroscopy for inspection of the human skin, engineered
normal skin and melanoma models and the quality of its data for utilisation in derma-
tological research has been studied.
Raman signatures of human and tissue engineered normal skin (frozen and wax embed-
ded) were investigated to determine if the layers have distinct spectral regions which
can be used for identification, and for the monitoring of the formation of these layers
in engineered human skin equivalents in culture. Several spectral regions, including
those associated with lipids and some protein markers, were isolated and shown to be
features that can be used to monitor skin maturation.
Raman signatures of engineered normal and melanoma models (frozen) were inves-
tigated to determine how the biochemical profile of melanoma tissue differs from en-
gineered normal tissue which were used as a baseline. Changes were found in protein
conformations and tryptophan configurations across the entire samples, in tyrosine and
in more fluid lipid packing in tumour dense areas of melanoma, and in increases of
glycogen content in the peri-tumour areas.
These findings suggest Raman spectroscopy may be helpful to theoretical and experi-
mental research on melanoma progression and clinical treatments.
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Chapter 1
Introduction
1.1 Background
Three dimensional skin tissue models were initially developed as substitutes to improve
healing and restore the skin barrier in patients with full thickness burns. From a com-
mercial point of view, the wound sector that it caters for is potentially very profitable.
For the treatment of chronic wounds in Germany alone, a European Commision report
suggested total annual sales to be in the region of 20 million euros in 2003, with a
real market potential of at least six times this value [Hu¨sing, Bu¨hrlen, and Gaisser
2003]. However, from their initial development as substitutes for wounded tissue [Met-
calfe and Ferguson 2007], application areas have since widened to testing of toxicity
and drug formulations [Netzlaff et al. 2005, Zhang and Michniak-Kohn 2012] to mod-
eling of various disease states such as eczamatous dermatitis [Engelhart et al. 2005]
and skin cancer [Carlson et al. 2008, MacNeil 2007]. They have proved good exper-
imental models for studying disease processes as their tissue architecture can mimic
those seen in human skin more closely. They are used extensively to improve under-
standing of wound response through monitoring contraction and collagen production
non invasively [Torkian et al. 2004] and study TGF-β function in re-epithelialisation
[Garlick and Taichman 1994]. Techniques that can assess the quality of these products
during culture, without the need of extensive sample preparation methods or that of-
fer additional, new perspectives are vital for the expansion of this industry. Methods
that assess tissue quality mostly either acquire morphological information (e.g. OCT,
MRI-MTC) or render the samples non viable through chemical treatments or external
labels (e.g. involucrin staining for keratinocyte differentiation status). It is proposed
that assessing the molecular nature of the skin with Raman Spectroscopy (RS) may
1
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provide complimentary information to many of the techniques commonly used in this
area [Edwards, Williams, and Barry 1995].
1.1.1 Normal skin
Skin is the largest organ constituting 15-20% of the total body weight. Its primary
function is to protect against environmental insults. It also possesses metabolic activ-
ity, delivers touch, heat and pain sensations via the peipheral nervous system, acts as
a thermoregulator and excretes salts and wastes. Homeostasis is maintained through
layers that have individual structures and functions, Figure 1.1.
Epidermis
The main function of the epidermis is protection against dehydration and invasion
by bacteria and microorganisms. It also provides a degree protection against mechan-
ical, thermal, chemical and UV insults. The zone itself is composed of five cell levels
(strata) starting with the stratum corneum at the air/skin interface down to the basal
level closest to the basement membrane (Figure 1.1). A fifth level, stratum lucidum,
is found only in load-bearing sites such as the palms and soles, known as thick skin.
All levels are predominantly composed of keratinocytes with melanocytes, langerhans
cells and merkel cells dispersed to varying degrees through the keratinocyte network.
A cell maturation gradient is observed within this zone. The basal level sees a contin-
uous proliferation of cells that constantly move upward. The cells start to lose their
nuclei and cytoplasmic organelles as they move up through the stratum spinosum and
granulosum and finally become the anuclear, keratinized cells of the stratum corneum
where they are routinely shed. The tissue turnover takes approximately 25-50 days.
Melanocytes only exist in the basal layer and have the primary function of produc-
ing melanin by utilizing tyrosine. Melanin gives colour to the skin, hair and iris of the
eye. It is considered a photoprotective substance. Upon exposure to sunlight, it absorbs
and transforms photon energy to heat leading to its dissipation. This process causes
the pigment to either degrade, photoionize or produce free radicals [Ortonne 2002].
The protection is primarily from the UV range as its absorbing ability decreases expo-
nentially from the UV to the visible range [Sarna and Swartz 1988]. Once produced,
the pigments are deposited into the membrane-bound melanosomes and are taken up
by keratinocytes, covering the nucleus and shielding it from UV radiation. Langerhan
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cells are antigen presenting cells found in the stratum spinosum that facilitate skin
allergic reactions. Merkel cells are mostly found in thick skin. These cells are attached
to nerve endings and act as mechanoreceptors. Keratinocytes make up >90% of the cell
population in the epidermis. They express the structural protein keratin and secrete
lipid to form the primary barrier to the outside environment. At the stratum corneum
level, the anucleated keratinocytes are embedded in a matrix of lipid by-layers, which
act as a water sealant. These cells are also immunomodulators. They secrete inhibitory
cytokines in the absence of injury while activating langerhans cells and triggering in-
flammation in the presence of injury.
Basement membrane
The basement membrane (BM) is a specialized extracellular matrix-protein complex in
the form of a semi-permeable membrane. It acts as an anchorage matrix for epithe-
lial cells that binds the epidermal and stromal zones. This boundary restricts transfer
of cells and molecules. There is also some opinion that the matrix facilitates repair
after injury by functioning as a scaffold for epithelial cells to migrate into. The zone
is composed of three layers starting with the lamina lucida closest to the epidermis.
An interim layer, lamina densa and the third fibroreticular layer closest to the stroma
(Figure 1.1). The four major components of the BM are type IV collagen, laminin,
entactin and perlecan. Type IV collagen and laminin are the most abundant proteins
making up the matrix. They self assemble into suprastructures bridged with entactin
and perlecan giving the protein matrix stability and structural integrity [LeBleu, Mac-
Donald, and Kalluri 2007].
The lamina lucida is composed mostly of laminin. Basal cells are bound to it through
focal points and hemidesmosomes. The lamina densa is composed of both laminin and
type IV collagen while the fibroreticular layer is composed of anchoring fibrils based on
type VII collagen that connect with type I collagen fibres in the dermis via anchoring
plaques. Fibrillin microfilaments of the dermis extend to the lamina densa crossing the
fibroreticular layer. The fibroreticular layer is composed of three different kinds of fi-
brous structures: anchoring fibrils, dermal microfibril bundles and collagen fibrils. The
first are asymmetrically cross-bonded fibrillar components, which extend the lamina
lucida at one end and the dermis at the dermal end, forming an interlocking meshwork.
The dermal microfibril bundles pass deeply into the dermis perpendicular to the BM.
Collagen fibrils are mostly randomly oriented with no junctional connection points.
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(a) Full-thickness skin diagram (b) H&E epidermis
Figure 1.1: (a) Skin components and structure (from [Gawkrodger and Ardern-Jones
2012) and (b) Epidermis of a tissue engineered skin stained with Haemotoxylin and
Eosin.
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Dermis
The dermis is the deepest zone of skin supporting the epidermis and gives it mechanical
strength. It is an avascular matrix composed of collagen, elastin and proteoglycans.
Housing blood and lymph vessels, hair follicles, sweat glands, sebaceous glands and
nerve endings, it acts as a thermoregulatory control for the skin and allows sensations
(touch, pressure, temperature, pain, etc.). The zone consists of two levels (Figure 1.1).
The papillary dermis, closest to the basement membrane, is composed of loosely packed,
thin, type III collagen fibres and few cells. Dermal papillae and nerve endings in this
level supply nutrients to the epidermis. The reticular dermis is a denser network of
closely packed type I collagen and elastin fibres in parallel arrangement to the skin
surface. Hair follicles, sweat glands and sebaceous glands are found in this level. The
primary cells of the dermis are; fibroblasts, macrophages and adipocytes.
The matrix acts as an active scaffold that helps define phenotypic differentiation of
cells residing within it. Fibroblast cells produce interlacing collagen and elastin fibers
that are housed in a glycosaminoglycan matrix. The glycosaminoglycans create a hy-
drated environment and give compressive strength to the matrix. This filling material
plays a major role in cell-cell signalling and can enhance or inhibit signalling activity.
The structural proteins, collagen and elastin, hold the dermis together. The blood
vessels transport nutrients and oxygen to the avascular upper layers of the skin and
deliver vitamin D to the rest of the body. Lymph vessels supply infection fighting cells
of the immune system whilst sweat glands achieve temperature regulation by delivering
water to the surface of the skin. Sebaceous glands secrete oils to waterproof the skin.
And nerve endings house touch and pain receptors to transmit sensations.
Tissue engineered (TE) skin substitutes don’t always try to mimic the entire skin struc-
ture seen in native skins. Instead, the construction varies by application. For toxicologi-
cal testing, different skin cells are often seeded onto sheets of synthetic (e.g. polyglactin)
or natural (e.g. collagen) polymers. For clinical use, they may be designed as single lay-
ers, such as dermis substitutes for chronic wound healing (INTEGRAr[Integra 2009]),
up to split or full thickness skin grafts (StrataGraftr[StrataTech 2014]). Although they
don’t usually contain every native skin cell type, they can form appropriate barriers
(for microbial defense and to prevent water loss) and even epidermal cell gradients close
to native skin. They make good experimental models for diseases such as melanoma.
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1.1.2 Melanoma
Incidence and mortality of melanoma is showing a marked increase in all countries
[Stewart, Kleihues, Cancer, et al. 2003]. In the UK, incidence rates increased >250%
between the years 1975-77 and 2006-08 [CancerResearch 2011]. This rise is higher than
any other cancer and has made melanoma the fifth most common cancer in the UK
[Globocan 2012]. Part of the increase is attributed to improved awareness, screening
and diagnosis of the disease. Although the number of melanoma cases is small relative
to the commonest cancer for each gender, incidence rates continue to increase, progno-
sis remains poor and it affects a young age group (Appendix). It is proposed that: (i)
the spectral fingerprints of melanoma may aid in screening the disease and that (ii) Ra-
man data may provide an additional perspective (different scale) in studying melanoma.
Etiology and Clinical features
Melanoma arises from cutaneous melanocytes found in the lower layer of the epider-
mis and may develop at any body site. The WHO recognizes ten subtypes based on
their difference in clinical and pathological growth patterns (Appendix), four of which
are considered major, Table 1.1. The subtype classification is not used as an inde-
pendent prognostic attribute and does not currently affect clinical management deci-
sions. Melanoma may arise de novo or within pre-existing melanocytic neavus [Longo
et al. 2011]. Initial symptoms patients are likely to recognize are an increase in size
of pre-existing moles or moles arising de novo with a surface area larger than normal.
Particularly Superficial Spreading Melanomas (SSM), which grow considerably in size,
and acquire irregularity in shape and colour. Acral Lentiginous Melanoma (ALM) pre-
senting as a flat, pigmented lesion on the palm or sole and are more difficult diagnose.
Initial symptoms for this type resemble those of an ulcer. Lentigo Maligna Melanoma
(LMM) arises from precursor lesions resembling freckles and as such may also go un-
noticed by patients. Rapid elevation of moles is a symptom favouring melanoma. This
is commonly seen in Nodular Melanoma (NM) as they quickly enter Vertical Growth
Phase (VGP). Histopathologically it is hard to discriminate between benign naevus
and those of melanoma if developed within pre-existing benign melanocytic naevi. The
reported percentage of melanoma cases arising from pre-existing benign naevi versus
those occurring de novo vary considerably from 20-30% to 40-50% due to this [Weath-
erhead, Haniffa, and Lawrence 2007, Bishop et al. 2007]. Pre-existing scars including
scars from previous biopsies may also be favourable to melanoma [LeBoit et al. 2006].
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Both familial and environmental factors have an effect on melanoma etiology. The
major risk factors are summarized in Table 1.2. Exposure to UV radiation is widely
considered the major risk factor with an estimated 80% of all melanoma cases being
attributed to sun damage to sensitive skin [Gandini et al. 2005b]. Causal pathways
appear to be different for the major subtypes. Intermittent exposure particularly in
childhood is a major determinant and the risk increases significantly if the individual
has immune deficiency or genetic disposition. SSM and NM, the two most commonly
diagnosed melanoma types more often present on intermittent sun exposed body sites
and largely affect the under 50 age group. LMM presenting on the head and neck
region is regularly linked to chronic sun exposure and is more common in the over 50
age group. It is postulated that familial traits alone, independent of environmental
factors, may constitute up to 3-15% of melanoma cases [Deˆbniak 2004]. And people
with a large number of moles have a 10-fold risk of developing melanoma compared to
those with few moles.
The clinical approach of detection from either origin is most commonly done through
the application of the ABCDE rule and/or 7-point checklist. Uneven symmetry and
pigmentation are the leading criteria. Not all melanomas will manifest every ABCDE
feature. It is the combination of features that suggest cutaneous lesions most suspi-
cious of melanoma [Rigel, Russak, and Friedman 2010]. The rule is shown to clinically
diagnose melanoma with sensitivities between 47-82% [McGovern and Litaker 1992,
Wolf et al. 1998, Ebell 2008]. However, the specificity is often much lower as many
benign melanocytic naevi may also display such atypical features [LeBoit et al. 2006].
The exception to the rule is regressing tumours, which are observed as whitish, grey
or black areas on the lesion. Many of the attributes highlighted by the ABCDE rule
are shared by both benign naevi and melanoma. The features therefore have to be
correlated with pathological findings and staged (see Appendix for melanoma staging).
Histopathological features I. Architectural
Proliferation of single melanocytes are seen in the earliest stages of melanoma. These
cells aggregate and start forming clusters as the lesion diameter increases to around
2-3 mm [Fernandez and Helm 2004]. The most important architectural features are:
(i) distribution of melanocytes, (ii) pigmentation, (iii) borders, (iv) confluence in nests
and (v) inflammatory infiltrates. These mostly involve assessment of symmetry. Any
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Table 1.2: Risk factors of melanoma (recreated from Gandini et al. 2005a, Gandini
et al. 2005b, Gandini et al. 2005c, Marsden et al. 2010])
Familial and Environmental Risk Factors
Phenotypic pigmentation traits, e.g. fair complexion
Having clinically atypical or a large number of naevi
Having a history of blistering sunburns
Having a personal or family history of MM
Immunosuppression
Intermittent high-dose or chronic exposure to natural or artificial sunlight
asymmetry in the distribution of melanocytes, pigmentation and lesion borders favours
melanoma. This includes whether or not the melanocytes are seen as single cells or
nests and their density distribution within the lesion (all on one side of the lesion or
scattered throughout). Pagetoid scatter for example usually suggests intraepidermal
melanoma. Size and shape of nests in the dermis is also important as well as how they
compare with nests in the epidermis. Apart from these, atypical mitotic figures (or
ones that are in clusters) and distribution of infiltrates of lymphocytes have diagnostic
importance.
Histopathological features II. Cytological
Melanocytes can vary greatly in size, shape and pigmentation between and within sub-
types of melanoma. They may be large or small, highly pigmented, oval, spindle-like
or dendritic in shape. Because of this, cytological features can be deceptive [McCarthy
and Scolyer 2010]. For example, melanocytes found in the dermis of desmoplastic
melanoma and epidermis of LMM are typically highly pigmented but large and pale
in the epidermis of neavi of the scalp [Massi and LeBoit 2013]. Whereas dendritic
melanocytes can be found in a number of different subtypes and skin colours. The
width of dendrites may in some cases be indicative of melanoma. Some examples of
histopathological features can be seen in Figure 1.2.
Markers
Melanoma markers are broadly divided into two groups: differentiation and progression
markers. Differentiation markers identify cells of melanocytic lineage but can be com-
mon to benign melanocytic lesions as well as melanomas [LeBoit et al. 2006]. Examples
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(a) (b)
Figure 1.2: Features of melanoma [LeBoit et al. 2006]. Architectural and cytological
features of cells are different compared to normal skin H&E.
include the surface proteins Melan-A and S-100 which play a role in immune recogni-
tion. Progression markers identify various molecules involved in pathogenesis. Down
or up regulation of their expression and their distribution are indicative of melanoma
stage. They include a wide range of molecules associated with proliferation (e.g. p16),
signalling (e.g. N-ras) or matrix degradation (e.g. MMP-2). A list of melanoma mark-
ers can be seen in Appendix.
Molecular features
Morphological classification of melanoma, in terms of its subtype, mainly defines the
pattern of growth. It is considered to have little prognostic value as survival correlations
using tumour thickness is much more accurate [Dickson and Gershenwald 2011, Wag-
ner et al. 2003]. However, there is growing consensus that subtype may be correlated
with somatic mutation. There are several such mutations identified in melanoma that
disrupt downstream expression and activity of proteins that are typically involved with
cell proliferation. Three of the classic oncogenes are BRAF, NRAS and KIT though
many more are being studied that may be common to types with enhanced metastatic
potential as well as subtype [Kunz 2014]. BRAF and NRAS mutations are found in
approximately 70% of all melanomas (mutually exclusive) [Broekaert et al. 2010].
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Progression
In the majority of melanoma cases, progression follows two stages before metastatic
spread: radial growth phase (RGP) and vertical growth phase (VGP). RGP describes
lateral expansion of the lesion. Growth is uneven but usually confined within the epi-
dermis. Any atypical melanocytes in the dermis at this stage do not have proliferative
capacity: they may survive without proliferating [Elder et al. 1983] or undergo apop-
tosis [Hsu et al. 1998]. In VGP, atypical cells in the dermis gain proliferative capacity
and mitotic figures can be seen. Expanding clusters in the dermis are often larger
than intraepidermal clusters. Metastasis is expected after this point. Typically, initial
spread is to regional lymph nodes but it is not uncommon to see distant metastasis in
other skin sites, lungs or liver in the absence of lymph node involvement.
Prognosis and Recurrence rates
There are several prognostic factors used in conjunction with clinical information, Table
1.3. Of these, ulceration, thickness and mitotic count are the major stage modifying
attributes of melanoma up to stage III. Mitotic count largely affects stage I in the clas-
sification system and is a strong marker for survival because it indicates the tumours
potential for metastasis [Clark et al. 1989]. At stage III, extent of lymph node inva-
sion becomes the major stage modifying factor while the significance of thickness and
ulceration decreases. Probability of 5-year survival is very different in patients that are
sentinel node negative (90%) versus positive (56%) [Yee et al. 2005]. And after Stage
III, the extent of metastases becomes the overriding factor. Significant recurrence rates
are observed for all after Stage IB, Table 1.4.
Melanoma invasion in TE models shows some similarities to those seen in native skins.
Depending on the type (aggressiveness) of the melanoma cells, the models may ex-
hibit pagetoid scatter in the epidermis, form large tumour aggregates that show both
RGP and VGP, or heavy dermal invasion. They are convenient alternatives to biop-
sies in preliminary studies for new analysis and imaging modalities such as Raman
Spectroscopy.
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Table 1.3: Prognostic factors of melanoma that need to be included in the histopatho-
logical report [Marsden et al. 2010]
Ulceration Growth phase
Thickness Regression
Mitotic count Tumour-infiltrating lymphocytes
Histological subtype Lymphatic or vascular invasion
Margins of excision Perineural invasion
Pathological staging Microsatellites
Table 1.4: Prognosis and recurrence rates for stages of melanoma (recreated from
CancerResearch 2011, Marsden et al. 2010)
Stage 5-year survival 10-year survival Recurrence rate
Stage 0 - - No risk reported after surgical
excision
Stage 1A 95% 87-89% <0.5mm has no recurrence
Stage IB 88-92% 78-85% 15-35% mostly within years 2-4
Stage IIA 77-79% 62-66% 15-35% mostly within years 2-4
Stage IIB 61-70% 49-57% 40-70% mostly within years 2-4
Stage IIC 43-47% 31-34% 40-70% mostly within years 2-4
Stage IIIA 57-73% 50-67% High risk of further metastasis
Stage IIIB 41-57% 29-53% High risk of further metastasis
Stage IIIC 20-34% 11-20% High risk of further metastasis
Stage IV 5-22% - High risk of further metastasis
1.1.3 Raman Spectroscopy
Raman scattering
The classic model of spectroscopy considers a simple molecule as a harmonic oscillator.
Attractive and repulsive forces are balanced in the equilibrium state. Monochromatic
radiation (an oscillating electric field) propagates through the sample and exerts a force
on the charges. The force deforms the bonds (the spring) pushing the molecule out
of equilibrium and inducing an oscillating dipole moment. The Raman effect depends
on the change in charge distribution that gives rise to the dipole moment, i.e. the
molecules polarisability. The periodic deformations actuate vibrational and rotational
transitions of the bond that vibrate at a characteristic frequency, exciting the molecule
to a virtual state. A small fraction of photons interacting with the molecule (approx.
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1 in 106–108) will experience an energy transfer and induce a change in the vibrational
state of a molecule (Figure 1.3). Radiation emitted from such oscillating dipoles will be
of different frequencies [Smekal 1923, Kramers and Heisenberg 1925, Landsberg 1928,
Raman 1928].
1. Rayleigh Scattering: Most molecules will feel a restoring force and the displace-
ment due to transitions will be fully recovered. The molecule returns to its origi-
nal vibrational state after excitation. The frequency of emitted radiation remains
unchanged from that of the incident (vincident = vlaser).
2. Stokes Scattering: If energy is transferred from the photon, the bond displacement
is not fully recovered and the molecule is restored to a higher vibrational state.
The emitted photon is shifted to a lower frequency (vstokes = vincident-vvib).
3. Anti-Stokes Scattering: If energy is transferred to the photon, a molecule in an
already excited vibrational state is restored to a lower vibrational state. The
emitted photon is shifted to a higher frequency (vantistokes = vincident+vvib).
The intensity of Stokes lines are more intense than anti-Stokes lines as the population of
molecules occupying a lower vibrational state will be higher according to the Boltzmann
distribution [McCreery 2005]. Energy of each bond/bond group (spring) vibration is
dictated by its vibrational force constant and will produce a characteristic shift in
frequency. The force constant is dependent on molecular structure and its environment,
e.g. atomic mass, geometry, organisation. The shift in frequency is represented by
∆υ and is termed the wavenumber. It gives the frequency of the scattered radiation
relative to that of the incident. It is plotted as a function of intensity to give the Raman
spectrum which is composed of all the Raman active bonds within the molecule under
investigation.
Atoms in a molecule have a number of modes of vibration. Each mode requires dif-
ferent excitation energies and will thus produce different Raman lines. The number of
vibrational modes of a molecule is given by:
Modes = 3N − 6 (1.1)
Where N is the number of nuclei in the molecule and degrees of freedom for the molecule
is 3N. Of these, three account for rotation and three (for non-linear) for translation.
This gives an upper limit to the number of Raman lines for a given molecule as some
modes may degenerate (have the same energy), may be Raman inactive (due to their
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Figure 1.3: Schematic representation of scattering modes after excitation for a simple
diatomic molecule: the harmonic oscillator model.
symmetry), or may not produce a line intense enough to be resolved from the back-
ground noise.
Consider Carbon Tetrachloride (CCl4). It is a tetrahedral molecule with four bond
pairs, each at a bond angle of 109.5 degrees to the central carbon atom. The molecule
has nine normal modes of vibration, of which, only four are Raman active (Table 1.5).
The symmetric stretch (1) is the most intense line as this bond has very high polarizabil-
ity. In comparison, the scissoring (2) and rocking (4) vibrations have lower intensities
due to lower vibrational force constants. And the asymmetric stretch (3) appears as a
doublet with two maxima at 790.4 and 761.7 cm-1.
Table 1.5: Raman active vibrational modes of CCl4 and corresponding shift positions
[Shimanouchi 1972]
Vibrational Modes Raman Lines (cm-1)
1 Symmetric stretch 458.7
2 Scissoring 217.0
3 Asymmetric stretch 790.4
3 Asymmetric stretch 761.7
4 Rock/Umbrella 313.5
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Interpretation of the spectrum becomes harder with more complex molecules which can
assume numerous conformations. For complex molecules, the use of mode frequencies
may broadly be put into two categories. Those from localized motions reflecting func-
tional groups (individual peaks) and those from bulk motions/properties, which may be
associated to large unique molecules (fingerprint bands). The functional group frequen-
cies may be used to find chemically specific information such as correlations between
spectral features and molecular structures. E.g. The 458.7 cm-1 band of CCl4 arises
from the combination of C-Cl stretching vibrations. The band can be further resolved
to display the ratio of Cl isotopes and give information on submolecular components
(35Cl or 37Cl). The fingerprint band frequencies by comparison often inform the ob-
server of larger scale properties such as chemical species. E.g. The four peaks that are
intrinsic to CCl4 and can be used to establish the presence of this molecule in a mixture.
The Raman effect is extremely weak compared to Rayleigh scattering. Its generation
and detection requires monochromatic light sources and sensitive detectors to isolate
the much weaker Raman lines from Rayleigh lines. There are two main instrument
setups, CCD-based and FT-based. They differ in the way in which the Raman scatter
is detected and analysed.
Instrumentation
CCD-based
A typical CCD-based dispersive spectrometer setup is shown in Figure 1.4. Laser
light is directed onto the sample. All backscattered radiation is collected through the
same path and returns to an optical filter.
Rayleigh scatter is much greater in intensity and will overwhelm the Raman signals
if not filtered. Optical filters are used to selectively filter the Rayleigh line whilst allow-
ing the weaker Raman scattered light through. There are two common types of filter
used in RS:
• Edge Filters: These can be long or short band pass filters. The filter absorbs
all wavelengths up to a specific point including the laser line and transmits all
wavelengths above (or below) the threshold point. Anti-Stokes scattered light
require short-pass filters, Stokes scattered light require long-pass filters. They
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typically have steep edges that can get very close to the laser line.
• Notch Filters: These filters block absorption of a specific wavelength range and
are used to absorb only the laser line. All wavelengths above and below the
blocked range are transmitted allowing both Anti-Stokes and Stokes scattered
light to be measured.
Raman spectrometers are typically setup with a range of lasers. Common laser wave-
lengths used are 514.5, 532, 633, 780, 785 and 1064 nm. Each laser requires an indi-
vidual filter designed to block that particular wavelength.
Figure 1.4: Simplified diagram of the main components of a Dispersive RS. This setup
displays a system with a green laser and an edge filter collecting Stokes scattered light
off the sample.
The Raman light transmitted through the optical filter is directed to a diffraction grat-
ing. This separates the Raman light into its composite wavelengths (each composite
wavelength is scattered at a different angle), and onto the CCD. The gratings will typ-
ically range from 150 l/mm to 4000 l/mm. The CCD chips are two-dimensional arrays
of light-sensitive elements (pixels). Each dispersed, composite wavelength is detected
by a different pixel (group of pixels). Position and intensity translates into the Raman
spectrum.
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FT-based
FT-based Raman systems use an interferometer to produce an interferogram of the
Raman scattered radiation. After excitation, a beam splitter divides the Raman scat-
tered light into two paths. One travels to and from a fixed reference mirror. The other
travels to and from a moving mirror. The two returning beams recombine and interfere
constructively or destructively depending on their path lengths. The interference pat-
tern is modulated by the polychromatic radiation. The resulting interferogram contains
information about every frequency of the Raman scattered radiation and is transformed
into a Raman spectrum. This type of spectrometer typically uses 1064 nm excitation.
The longer wavelength excitation decreases the likelihood of sample fluorescence.
There are several practical reasons RS is an attractive technique for studying biological
systems: (i) It does not require any dyes or probes so samples may be used for other
purposes after RS analysis. (ii) It requires minimal sample preparation. Many of the
tissue preparation methods used for other types of analysis can usually be adapted for
RS analysis easily. (iii) Raman spectra are information-rich. The chemical fingerprint
may be used to quantify multiple components of the sample using the same data set:
potential for fewer tissue sections to measure several different components. (iv) It is
also insensitive to water and can be coupled with fiber optic probes for remote and
no-contact analysis. This is useful in skin analysis as it means data can be collected in
situ from patients as well as from tissues in culture.
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1.2 Aims
The aim of this project was to determine the potential value of Raman spectroscopy,
specifically the type of quantitative and qualitative information that may be extracted
from Raman analysis of 3D skin models and tissue engineered models of melanoma.
Experimental objectives were as follows:
1. Determine the influence of different sampling methods of skin tissues on the Ra-
man data obtained.
2. Determine the applicability of RS data for the identification and evaluation of
the different layers of skin based on a study of intact skin and tissue engineered
skin models.
3. Determine how useful RS data is in studying the interaction between melanoma
cell lines and adjacent normal tissue using 3D tissue engineered models of melanoma.
Chapter 2
Literature Review
2.1 Introduction to the medical and biological applica-
tions of Raman Spectroscopy
A Raman spectrum is composed of all the Raman active bonds within a sample un-
der investigation (Chapter 1). The spectrum is like a fingerprint which holds true for
every identical sample under the same defined conditions. Changes to composition
or in conditions that alter a physical property (e.g. crystallisation) result in changes
to the spectrum as the type or environment of bonds change. Disease states, hydra-
tion/dehydration, trauma of the skin all cause changes to its biochemistry from normal
state which are reflected in the spectra. To date, RS has been used to successfully
differentiate tissues from different organ sites and a wide range of cancer types. Spec-
tral differences between lung, liver and kidney tissues obtained from rats and pigs can
be used to not only identify organ type but the species from which the samples were
taken [Lorincz et al. 2004]. Lipid and protein content of breast tissues were found
to be markers for benign and malignant states [Chowdary et al. 2006], keratin and
tryptophan to be sensitive to separating normal and SCC tissues [Devpura et al. 2012]
whereas differences to protein conformations and phospholipids were used to classify
tissues of the stomach [Teh et al. 2008]. The applications are far-reaching and extensive
due to flexibility in choices for sampling. Spectral features detectable in high resolution
RS also offer information at the cellular level. Cells undergo specialized differentiation
in order to perform specific functions, and produce specific biochemicals. B-cells se-
crete insulin, melanocytes produce melanin and neurons produce neurotransmitters.
RS can be used to measure the different cell lines without the use of an external label
and potentially, non invasively. It can be used to detect changes arising due to cell
19
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differentiation [Swain and Stevens 2007], drug interactions [Owen et al. 2006] and as
alternatives to conventional cell biology assays [Pascut et al. 2013, Pudlas et al. 2011].
The specificity of RS is also shown to be sensitive enough detect many cellular compo-
nents within single cells. For example, the distribution of proteins [Uzunbajakava et al.
2003], lipid deposits [Wood et al. 2008] and organelles [Krafft et al. 2005].
2.2 Raman analysis of normal skin tissues
Raman bands corresponding to components of the skin have been assigned from studies
using a variety of laser wavelengths and with skins that have been processed differently
[Edwards, Williams, and Barry 1995, Barry, Edwards, and Williams 1992, Shim and
Wilson 1996]. Spectra have been documented from sebaceous glands, nails, hair and
sweat ducts [De Faria and De Souza 1999, Caspers et al. 1998]. It has potential in
both extracting explicit information from the skin regarding molecular composition
and using the spectra as highly specific fingerprints to identify or classify the tissue.
For example, it has been used to detect changes in carotenoid concentrations in actinic
keratosis [Hata et al. 2000] and to show that keratin is not structurally altered in hy-
perkeratotic conditions such as psoriatic plaques [Edwards, Williams, and Barry 1995].
Layers have been identified by comparing skin spectra at different depths to spectra
collected from components that are known to be abundant in each layer. Lipids in
the stratum corneum [Chrit et al. 2005, Gniadecka et al. 1998, Tfayli et al. 2013] and
collagen in the dermis [Flach and Moore 2013, Ali et al. 2013c].
Lipids of the stratum corneum have been studied extensively with Raman spectroscopy.
Lipid composition is important for SC function and regulation [Silva et al. 2006]. And
the order of lipid packing determines SC permeability. Raman spectroscopy has been
used to determine composition, such as the relative proportion of the major SC lipids:
ceramides, cholesterol and fatty acids [Percot and Lafleur 2001]. Raman spectra of
these components have also been studied under different experimental conditions that
alter their lamellar structure. Lipid phase dependence on temperature has been shown
both in mixtures [Wegener et al. 1996] and in mixtures supplemented with additives to
lower phase transition temperatures [Neubert et al. 1997]. It is reported that relative
population of trans and gauche phases can be determined as accurately as differential
scanning calorimetry using the raman regions 3200-2800 (υCH2) and 1150-1050 (υCC)
cm-1. A lateral packing value based on the (υCH2) vibrations has been accepted and
used for some time [Gaber and Peticolas 1977, Gniadecka et al. 1998]. The value is
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based on the ratio of intensities for peaks at 2880 and 2840 cm-1 and produces a cal-
ibration chart from 0 (liquid state) to 1 (crystal state). Measurements of the lateral
packing order gives an indication as to the barrier function of the SC and its capacity
to prevent water loss.
Water content of the SC and underlying epithelial layers maintain SC flexibility and
barrier properties. In this regard, water content is thought to be more important than
oil content [Blank 1952]. As it has a direct effect on barrier function, water loss in-
creases with skin damage. Transepidermal water loss (TWL) measurements are used
in dermatological research to evaluate the rate of water loss, and by relation, barrier
function. One of the most interesting applications of Raman spectroscopy on skin is the
measurement of water profiles across skin layers. The ratio of the water band (-OH) at
3250 cm-1 to the overall protein band at 2930 cm-1 gives a value for the amount of water
present per amount of protein. The method has been used to produce profiles for water
concentration down to 250 µm below the skin surface [Caspers, Lucassen, and Puppels
2003, Caspers et al. 2001]. It shows water content to be low in the SC but much higher
in the epidermis. Water holding properties of the viable epidermis is different enough
to use this ratio to determine borders of the SC [Caspers, Lucassen, and Puppels 2003].
The same method has also been shown to measure water content of the dermal layers
in patient forearms at up to 175 µm below the skin surface [Nakagawa, Matsumoto,
and Sakai 2010], who detected higher amounts of dermal water in elderly patients. This
sort of measurement is important in assessing skin conditions in patients (e.g. much
greater water loss with eczema) but in particular, it has great potential in assessing
new artificial skins and testing efficacy of new products to improve skin hydration.
Research into tracking various topical formulations into skin with Raman spectroscopy
is also increasing. As the formulations are typically strong Raman scatterers, tracking
their penetration has often been shown to be fast and reliable [Fo¨rster et al. 2011, Tosato
et al. 2012]. A practical example is evaluation of the efficiency of delivery vehicles for
trans-cinnamaldehyde which used their Raman signatures to trace their penetration
into skin over time [Bonnist et al. 2011a]. Where Raman based values for the rate of
transport were found to be quite accurate. Another study looked into conditions that
increase absorption of toxic chemicals into skin [Broding et al. 2011]. This study mon-
itored absorption of 2-butaxyethanol in water and ethanol on patients skins. Depth
profiling approaches have also been compared to drug permeation into tissue sections
to up to 50 µm depth [Tfayli, Piot, and Manfait 2008]. This type of study appears
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currently to be limited to tracing products only. However, there is great potential in
using Raman data to determine effects said formulations have on skin biology. Raman
spectra are already being used to study changes to the composition of skin layers with
some skin conditions such as hyerkeratotic psoriatic plaque [Edwards, Williams, and
Barry 1995] and atopic dermatitis [O’Regan et al. 2010]. And the effects of external
insults such as radiation damage from sun exposure. Radiation damage induced onto
artificial skins have shown an increase in lipid signatures of the SC and protein damage
early on followed with loss of DNA bands later [Ali et al. 2013a]. It is reported that
the effects can be observed in Raman spectra at earlier time-frames compared to MTT
assays.
2.3 Raman analysis of skin cancer
Skin cancer diagnosis and classification remains to be based on visual observations.
Sensitivity and specificity of screening varies depending on the experience of the der-
matologist. As it is subjective, excessive biopsies are taken in many cases. It is sug-
gested that up to 80% of biopsies taken by non dermatologists turn out to be benign
[Jones, Boiko, and Piepkorn 1996]. Histological classification, though very accurate, is
intrusive, time consuming and requires expertise. RS has been recommended for the
pre-selection of samples prior to excision, during surgery to ascertain tumour borders,
and in studying localised effects around tumour borders in vitro. These altogether en-
compass both clinical (screening, diagnosis) and research areas of skin cancer making
RS a potentially fruitful endeavour.
The commonest type of skin cancer is basal cell carcinoma (BCC) followed by squamous
cell carcinoma (SCC). They account for approximately 75% and 20% of all reported skin
cancer cases respectively [CancerResearch 2011]. BCC originates from keratinocytes,
and typically grows slowly. It is not often associated with metastasis but it can cause
local tissue damage if left untreated. Clinical diagnosis accuracy is only around 65% for
practicing dermatologists [Gniadecka et al. 1997]. Several groups have shown various
predictive classification methods can separate whether or not Raman spectra are col-
lected from BCC or normal tissue. In these papers, BCC is identified with accuracies
sometimes exceeding 90% both in vivo and ex vivo. Some major findings as to the origin
of spectral differences and classification accuracies for BCC, SCC and normal tissues
are presented in Tables 2.1, 2.2, 2.3, 2.4. Most of these studies report differences in the
Amide bands and in the region 1000-600 cm-1.
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The skin cancer with the highest mortality rate is melanoma. Several groups have
shown the Amide I band is reduced in intensity and broadened for melanoma samples.
Changes to the amide bands in fact appear to be a common feature for most skin can-
cers and some benign conditions (Table 2.1). Authors mostly attribute spectral changes
that are similar between for example normal to BCC and normal to melanoma to ma-
lignant transformations that are independent of tissue type. That the transformation is
likely to trigger some similar molecular changes in tissues. But despite some similarities
between different types of skin cancer spectra, BCC, SCC and melanoma, classifica-
tion models setup for two or more of these types are able to discriminate malignant
tissues from both normal tissue (quite accurately), and from each other (somewhat less
accurately). For example, melanoma has been identified with a sensitivity 85% and
specificity of 99% using neural networks in a data set collected from BCC, melanoma,
seborrheic keratosis (SK) and normal skin [Gniadecka et al. 2004]. Differential diagno-
sis of melanoma has in fact been shown in several large data sets comprised of various
skin lesions often confused with melanoma [Zhao et al. 2008, Lieber et al. 2008b]. And
features from spectra of tissue components such as melanin, type I and III collagen,
actin, triolein and nucleic acid DNA were also used to setup models in order to compare
their sensitivity toward separating BCC, melanoma and normal tissue [Silveira et al.
2012]. Type III collagen and actin were found to perform well in separating BCC from
both normal tissue and melanoma. Features of DNA were of higher intensity for BCC
compared to normal tissue, and even higher for melanoma. This is expected in malig-
nant transformation due to increased cell replication rates. The skin cancer studies also
reveal differences in optical properties between cancerous and normal tissue. Cancer-
ous lesions show much higher absorption and less scattering compared to normal skin
[Rajaram et al. 2010, Fendel and Schrader 1998] and pigmentation is found to correlate
with higher backgrounds but are reported to be easily handled [Philipsen et al. 2013].
Collection of Raman data from intact samples remains difficult but has greatly im-
proved over the last decade. In vivo studies often lacked the higher SNR and resolution
seen in spectra collected from fixed tissue sections before the advance in fiber optic
probes. While they may still result in more intense processing of the spectra, tissue
type differences in some cases, remain large enough for accurate and reliable classifi-
cation. Raman spectra have previously been collected in vivo from lesions suspected
of non melanoma skin cancer at depths of 40 µm below skin surfaces [Lieber et al.
2008a]. Where four types of tissue, SCC, BCC, scar tissue and normal tissue, were
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correctly identified with an accuracy of 95% using only the Raman spectra. Interest-
ingly, a punch biopsy was taken from each lesion after Raman measurements and it
was noted that 40% of the lesions biopsied (as part of the treatment determined by
the clinician) were actually scar tissue. Another study was able to discriminate BCC
from surrounding tissue in vivo with similar accuracies using only the high wavenumber
band of lipids between 2800 and 3100 cm-1 using LDA [Nijssen et al. 2007]. It is also
suggested that this region may perform well in discriminating different cancer types
[Gniadecka et al. 2004]. One large in vivo study included 518 samples of melanoma,
BCC, SCC, actinic keratosis (AK), atypical nevi, melanocytic nevi, blue nevi and SK
[Lui et al. 2012]. Skin cancers were separated from benign lesions with a sensitivity
of 90% and specificity of 64%. Raman spectra were also used to accurately separate
inflammatory skin conditions eczema and psoriatic skin from kaposi sarcoma [Fendel
and Schrader 1998].
From a clinical point of view, apart from screening, accurate and reliable detection
of tumour borders has significant impact on the success of treatment. Inaccurate de-
termination of tumour borders causes high 5-year recurrence rates for primary BCC.
This is reported to be as high as 10% with conventional surgery versus 1% with Mohs
micrograph surgery [Rowe, Carroll, and Day 1989]. This type of surgery removes the
tumour layer by layer whilst analysing each removed layer under a microscope simul-
taneously. Tumour margins are much more accurately determined compared to wide
excisional surgery. There is increasing research into collecting Raman data from large
areas to optically locate non-disease borders. Raman profile maps of BCC tissue sec-
tions have been shown to not only differentiate between normal and malignant areas
[Baek et al. 2006, Choi et al. 2005] but also show that the spectra collected from dermis
near tumour borders differ from the bulk dermis spectra [Nijssen et al. 2002, Nijssen
et al. 2007]. The spectra reveal clear differences in the Amide I region, which shifts
to a lower wavelength and becomes broader. Whilst the protein and lipid mode at
1454 cm-1 and Amide III regions are of much lower intensity for normal tissue. Cancer
field effects have also been studied on tissue rafts. Dermal tissue on rafts seeded with
fibroblasts and fibrosarcoma cells were found to differ in the vicinity of the tumour at
855 cm-1 (amino acid peak of tyrosine and proline) and in the Amide III band between
1340 and 1250 cm-1 [Lieber, Nethercott, and Kabeer 2010].
As for the use of RS in pure cancer research, the weakness lies in the inevitability
of mode mixing as many tissue constituents have overlapping peaks/bands. RS can
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detect C-C, C-N and C=O vibrations of all proteins within the tissue. The overlap of
these vibrations for the large protein mix result in broad features and makes it diffi-
cult to identify individual proteins against a background of many other proteins. In
tissue, the overall protein (or lipid, or DNA) contents are more often used to ascertain
information on these species. For example, Amide I band between 1710-1620 cm-1: the
main contributor to the band is the C=O vibrations of protein peptide groups which
represents the protein backbone geometry. For healthy normal tissue, in the absence of
any external irritant, proteins are expected to have particular conformations and hence
a specific Amide I position that represents normal function. In pathological tissue,
expression of numerous proteins may be disrupted (upregulated, inhibited, etc.) or
result in abnormal conformations. Changes in protein geometry or concentration will
be reflected in this band (as shifts or changes to bandwidth etc.) allowing its detection.
But, while an overall observation can be made of some change in protein products, it is
very difficult to assign the change to an individual protein. Whilst many of the papers
listed in Tables 2.1, 2.2, 2.3, 2.4 mention some change to the Amide I and III bands,
conjectures about any reasons as to the cause of change is only moderately attempted.
Raman spectroscopy papers handling skin cancer samples therefore appear to often
focus on classification for screening purposes.
2.4 Emerging Raman techniques and their applications in
life sciences
Stokes line intensity is proportional to laser intensity, and inversely proportional to
excitation wavelength (Istokes 1/ λ
4). Choosing a shorter wavelength increases Stokes
line intensity, however, fluorescence is also wavelength dependent and typically in-
creases with shorter wavelengths. This requires a trade-off between obtaining higher
signal intensities at shorter wavelengths versus lower background at longer wavelengths.
Sample concentration also has influence over line intensity. And choice of wavelength
can change depending on factors such as sample thickness, phase, required measure-
ment depth and the substrate on which the sampling is made. There are a number of
emerging Raman setups that can increase line intensity using resonance effects.
For example, Resonance Raman Spectroscopy (RSS) occurs when the excitation fre-
quency matches that of an electronic transition of an analyte. The transition increases
the magnitude of the oscillating dipole moment. The resonance, when combined with
CHAPTER 2. LITERATURE REVIEW 26
the freqeuncy of the laser generating the Raman signal, can result in line intensity
increases in the order of 106 [McCreery 2005]. It is an alternative to increasing con-
centration. The method has been used to detect carotenoid concentrations in human
skin stratum corneums non invasively [Ermakov et al. 2005]. Carotenoid levels were
shown to correlate well with oxidative stress levels in subjects independent of dietary
consumption. Haemoglobin oxygen saturation has also been measured in rats with
deep violet excitation [Ward et al. 2007] and in single trapped blood cells [Gessner
et al. 2004]. Interference from fluorescence is often a problem and may overwhelm
the Raman signal making detection of the RRS signals over the background difficult
for many samples. Also, the technique works only on spectral regions where the laser
matches the appropriate electronic transition wavelength, limiting applicability (E.g.
resonance of carotenoids closely matches 488nm excitation).
Surface Enhanced Raman Scattering (SERS) enhances Raman signals of analytes when
they are absorbed onto or near the surface of certain noble metals. Collective oscilla-
tions of the conduction electrons (plasmons) move freely within the metal. The surface
plasmons resonate upon excitation and are coupled with the energy of the incident
radiation if the frequency of the excitation laser matches that of the plasmons. The
effect is typically confined to local fields but the raman signals may be amplified by 103-
107. It is an alternative to increasing laser intensity. The technique allows a wide
range of inorganic and organic analytes, including single molecules, to be observed with
much lower acquisition times and laser powers. It also greatly improves the detection
limit of low concentration solutions. Classical Raman setup is able to detect Adenine
in solution at down to 10-3 M concentrations, while with SERS the detection limit is
increased to concentrations as low as 10-8 M [Ka¨mmer et al. 2014]. Many groups have
combined this technique to make use of the SERS enhancement in microfluidic devices
to detect single cells and create rapid cell sorting assays for bacteria [Li et al. 2012].
SERS has also been used to create cellular pH maps within pH limits between 2 to 8,
allowing the detection of cell reactions to external stimuli [Wang et al. 2008, Bishnoi
et al. 2006]. Functionalizing the nanoparticles to detect specific molecules of interest is
worth particular mention. The potential for combining substrate particles with various
tumour-targeting antibodies is an exciting area gaining rapid interest. Oral cancer cells
were found to align to gold nanorods containing antibodies targeting epidermal growth
factor [Huang, Ernberg, and Kauffman 2009] and liver cancer cell were targeted with
silver nanoparticles containing antibodies HER2 and CD10 [Kim et al. 2006]. The en-
hancement effect decays considerably with increasing distance form the metal surface,
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which poses a limitation for this technique. Reproducing surfaces with identical states
of aggregation and roughness is also difficult and requires highly controllable deposition
methods. The typical metals used also photodecompose giving the produced substrate
limited operational time.
Raman signals may also be enhanced via nonlinear excitation as seen in coherent anti-
Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS) that are
beyond the scope of this review. Briefly; they involve a pump and Stokes laser that are
incident on the sample. When the frequency difference between the pump and Stokes
beams matches the Raman transition of a chemical bond, the molecular oscillations
are coherently driven. In CARS, a second pump laser further interacts with the now
excited chemical bond to give rise to an anti-Stokes signal several orders of magnitude
greater than spontaneous Raman signals. In SRS, the enhancement arises from an en-
ergy transfer from the pump to the Stokes beam when the frequency difference matches
a Raman transition. The techniques are chemically specific as only selected molecular
vibrations are amplified. This brings some particular advantages including faster data
acquisition (by focusing all energy to track a single bond) and also in cases where two
components have Raman peaks in the same position, it may be possible to differentiate
each component by shaping the pump pulse to each component. They have been used
for video-rate imaging of tissues and to monitor drug delivery into skin [Saar et al.
2010, Belsey et al. 2014, Mansfield et al. 2013, Galli et al. 2014, Friedrich et al. 2015,
Evans et al. 2005].
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Chapter 3
Materials and Methods
The research described in this thesis has been carried out on fresh skin and engineered
3D models of normal skin and melanoma. Freshly isolated primary keratinocytes and
fibroblasts were used to make up normal skin models. In addition to the normal skin
cells, two melanoma cell lines were used to construct models for A375SM and C8161
type melanoma. The composites were set up sporadically over a 3 year period. Most of
the normal skin cells were therefore cryopreserved in liquid nitrogen following isolation
and expansion, then thawed as required. The melanoma cells were kindly donated by
other staff in the laboratory who were expanding them, Ahtasham Raza and Shweta
Mittar (see Section 3.1.2 for origin). The complete process for the construction of
the models is depicted in Figure 3.1. All samples were fixed in formaldehyde and
embedded in preservation media for subsequent histological investigation and Raman
spectroscopic analysis. The method of processing depended on whether or not they
were wax-embedded or cryo-embedded. The only exception to this was in vivo mea-
surements on intact skin where an extra set of Raman measurements were carried out
on fresh tissues (native or HSE) before formaldehyde fixation.
A full list of all cell and tissue culture consumables can bee seen in Appendix.
3.1 Cell and Tissue Culture
3.1.1 Fresh skin samples
Fresh skin samples were obtained during routine plastic surgery breast reductions and
abdominoplasties from the Royal Hallamshire Hospital (Sheffield, UK). All skin sam-
ples were taken with written patient consent, for research purposes -only- and kept
32
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anonymous. Samples were handled under the Human Tissue Authority (HTA) license
12179. The skin supply was split into three and used for: 1- Raman measurements on
native human skin as is, 2- isolation of primary skin cells and 3- preparation of De-
epidermised Dermis (DED). The skin samples for cell isolation and DED preparation
were processed within 24 hours. Samples for native skin measurements were kept in
PBS at 4◦C until required.
3.1.2 Cell culture
All cell culture work was carried out in Class II Microbiology Safety Cabinets. The
cabinets and surgical items used within were sterilised with 70% (v/v) Industrial Methy-
lated Spirit (IMS) or by autoclave sterilisation. All cell culture media was warmed to
37◦C in a water bath before use. All cell and tissue cultures were incubated at 37◦C
in humidified incubators with air containing 5% CO2. Cells were always thawed from
frozen, expanded in a flask and then added to composites. This was to ensure the cells
seeded onto composites were all viable.
Passaging and storage
Passaging cells
Cells were passaged when they reached approximately 70-80% confluence to allow
healthy proliferation to continue. To passage, cells were washed with PBS and detached
using 0.1% (w/v) trypsin (keratinocytes were detached using 0.02% (w/v) EDTA fol-
lowed by trypsin). The cells were suspended in cell culture media and spun down in a
centrifuge at 1000 rpm for 5 minutes. The supernatant was discarded and the pellet
was resuspended in cell culture media. A cell count was carried out using a haemocy-
tometer and the appropriate number of cells were either: i. seeded onto composites, ii.
passaged into new cell culture flasks, or iii. frozen down.
Freezing cells for cryopreservation
For cryopreservation, cells were treated as for passaging. After the cell count, the cell
suspension was spun down again and the cellular pellet was resuspended into cryop-
reservation media. This media consists of 90% fetal calf serum (FCS) and 10% dimethyl
sulphoxide (DMSO). The volume of cryopreservation media was made up so as to give
a concentration between 2-3 million cells per ml of suspension. 1 ml of this suspension
was pipetted into each cryovial and placed into a Nalgene Cryo freezing container. The
container was placed in a -80◦C freezer overnight. Cryovials were then transferred into
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a liquid nitrogen dewar.
Thawing frozen cells
Cryovials were removed from liquid nitrogen and quickly thawed in the palms of the
hand. The cells were diluted in cell culture media and centrifuged at 1200 rpm for 5
minutes. The supernatant was discarded and the cell pellet was resuspended in cell
culture medium.
Human keratinocytes
Keratinocyte culture was carried out in Keratinocyte Culture Medium (KCM). This
medium consists of Dulbecco’s modified eagle’s medium (DMEM) and Ham’s F12
medium in a 3:1 ratio supplemented with 10% FCS, 5 ml glutamine, 5 ml Peni-
cillin/Streptomycin solution, 1.25 ml fungizone, 2 ml adenine, 2.5 ml Insulin, 500 µl
triiodotyronine, 80 µl hydrocortisone, 2.5 ml EGF and 500 µl cholera toxin.
Their isolation followed a previously described protocol [Eves 2001]. Briefly: split
thickness skin grafts were obtained from theatres as previously described. Samples
from this skin were cut into 0.5 cm2 pieces using a scalpel blade and were incubated
overnight at 4C in a universal with Difco Trypsin (DT). Skin pieces were then placed
into a KCM containing petri dish and the epidermal layer from each piece was gently
peeled off using a pair of forceps. A scalpel blade was used to gently scrape basal
keratinocytes from the undersurface of the epidermis and from the papillary surface of
the dermis. The de-cellularised epidermal parts were discarded and the de-cellularised
dermal parts were put aside for fibroblast isolation. The cell suspension was transferred
into a universal container and centrifuged at 1000 rpm for 5 min. The cells were resus-
pended in fresh KCM. 3-5(106) freshly isolated keratinocytes were seeded onto a feeder
layer of irradiated 3T3 (i3T3) cells in a T-75 flask. They were incubated until approxi-
mately 80% confluent with a media change every 2-3 days. When passaging, the flasks
were incubated in 0.02% (w/v) EDTA to detach i3T3s and then 0.1% (w/v) trypsin to
detach keratinocytes. These cells were frozen down at passage 0 or 1 and only used to
seed onto composites up to a maximum of passage 3. For composite experiments, they
were suspended in KCM and seeded at a density of 3(105) cells per composite.
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Human fibroblasts
Fibroblast culture was carried out in Fibroblast Culture Medium (FCM). This medium
consists of DMEM supplemented with 10% FCS, 5 ml Penicillin/Streptomycin solution,
1.25 ml fungizone and 5 ml glutamine.
The dermal parts were collected as described in the previous section. These dermal
samples were washed several times in PBS and then finely minced with a scalpel blade.
The mince was incubated at 37C overnight in Collagenase A solution. The following
day, the collagenase digest was spun down in a centrifuge at 1000 rpm for 10 minutes,
the supernatant was discarded, and the pellet of cells was resuspended in FCM. Fibrob-
lasts were seeded into T-25 flasks in the first instance and then T-75 flasks thereon.
Cells were passaged when fibroblasts reached 80% confluence using 0.1% (w/v) trypsin.
They were frozen down between passage 3 and 6 and seeded onto composites up to a
maximum of passage 9. For composite experiments, they were suspended in FCM and
seeded at a density of 1(105) cells per composite.
Human melanoma cells
A375SM
The A375SM cell line was obtained from Professor I J Fidler via M J Humphries (Uni-
versity of Manchester) [Eves 2001]. It is from lymph node metastasis of a 54 year old
female. These cells were maintained in Eagle’s modified essential medium (EMEM)
supplemented with 10% FCS, 2uM l-glutamine, 100 IU/ml penicillin and 100 ug/ml
streptomycin, 1.2 ugml(-1) fungi zone, 1.5% (100x stock) vitamin concentrate, 1mM
sodium pyruvate, 10% non essential amino acids and 0.187% sodium bicarbonate at
37C. They were passaged using 0.1% (w/v) trypsin. For composite experiments, they
were suspended in KCM and used at a density of 5(104) cells per composite.
C8161
The C8161 cell line was a gift from Professor F Meyskens via M Edwards (University
of Glasgow) [Eves 2001]. It is from an abdominal wall metastasis from a woman with
recurrent malignant melanoma. They were maintained in supplemented EMEM as for
the A375M cell line. They were passaged using 0.1% (w/v) trypsin. For composite
experiments, they were suspended in KCM and used at a density of 5(104) cells per
composite.
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3.1.3 Tissue culture
Preparation of De-epidermised dermis
Skin pieces approximately 1.5 cm2 in size were cut using a surgical blade and immersed
in 1M sodium chloride overnight at 37◦C. The epidermis was then peeled away from
the dermis using forceps. The piece of dermis left behind is referred to as DED. It is a
structurally intact dermal component that retains basement membranes. For storage,
the DED was washed in PBS several times and kept in KCM at 4◦C until required.
Composite construction
The DED were prepared as described previously and placed into a six well culture
plate with the papillary surface uppermost. Sterile stainless steel rings (0.8 cm inside
diameter) were placed on top of each DED piece and gently pushed down to form
a liquid tight seal between the ring and the DED. The well surrounding the ring was
flooded with FCM, keeping the inside of the ring empty, and incubated for several hours
to check a liquid tight seal had formed. Upon confirming a seal had formed, fibroblasts
were added to the inside of each ring at a density of 1(105) cells per composite. The
rings allowed a cell suspension volume of approximately 300 µl. After 24 hours of
incubation at 37C, the FCM surrounding and within the ring was carefully removed.
For melanoma models, melanoma cells suspended in KCM were added inside the ring
at a density of 5(104) cells per composite. The well surrounding the ring was re-flooded
with fresh KCM and the composites were incubated for a further 24 hours. On the
third day, the media inside the ring was removed and replaced with keratinocytes at a
density of 3(105) cells per composite. The media surrounding the ring was also replaced
with fresh media. After another 24 hour incubation, the rings were removed and the
composites were transferred onto stainless steel grids in a fresh six well culture plate.
KCM was added into the wells so as to cover the edges of the grids where the bottom
surface of the composite was in contact with media while the top surface was exposed to
air. In this way the grids supported the composites at an air-liquid interface (ALI). The
melanoma composites were then incubated at ALI for 14 days with a media exchange
every 2-3 days. For normal skin models, keratinocytes were added following the first 24
hours incubation with fibroblasts. Normal composites were incubated at ALI for either
7 or 14 days. All completed models were fixed in 3.7% formaldehyde for a minimum of
24 hours before further processing.
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Figure 3.1: Diagram highlighting the steps of construction for tissue engineered skin
models. It takes approximately one month to produce a skin model.
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3.1.4 Preserving models
Wax embedding
Following fixation in formaldehyde, these samples were placed flat in tissue cassettes
and processed overnight in a Leica TP1020 bench top tissue processor. The full list
of solutions tissue is processed through can be seen in Appendix. Samples were then
embedded in wax (Leica EG1160 embedding centre), cooled on ice blocks and stored at
-20◦C until required. 6-10 µm (H&E) and adjacent 10-25 µm (RS) thick sections were
cut from each sample block using a microtome (Leica RM2145 microtome).
Cryo embedding
Following fixation in formaldehyde, samples were placed in 30% (w/v) sucrose in PBS
for a minimum of two hours. The samples were then sandwiched between layers of
Optimum cutting temperature (OCT) compound (Leica biosystems, UK) inside cry-
omoulds. The cryomoulds were gently lowered into a bath of liquid nitrogen. Once
frozen through, the samples were stored at -80◦C until required. A Leica cryostat (Le-
ica CM1860 UV) was used to cut adjacent sections to a thickness of 6 µm onto glass
slides for H&E staining, and to 20-25 µm onto either glass, quartz or CaF2 for Raman
analysis.
3.2 Tissue characterisation
3.2.1 Haemotoxylin and Eosin staining of tissue sections
All skin samples were stained with Haemotoxylin and Eosin. Paraffin embedded sam-
ples were washed in xylene and alcohol, followed by staining then repeat washes in
reverse order. Cryo sections were first washed in PBS, stained and then dehydrated in
alcohol. Full details of the staining steps can be seen in Appendix. Stained sections
were allowed to dry for 10 minutes and sealed off with cover slips.
3.2.2 Sample preparation for Raman analysis
Intact skins
For Raman measurements on intact native skin, fresh skin samples from theatres were
cut into 0.5-1 cm2 pieces with a scalpel blade. The pieces were placed in a custom
made stainless steel well block and enough PBS was added inside of the well so as to
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keep the underside of the skin hydrated. A sapphire window of 2.5 cm diameter and
0.5 cm thickness (UQC Optics, UK) was used to seal off the well. The same procedure
was also followed for some intact HSE measurements though approximately half of all
HSE profiles were performed as is in their cell culture plates: Raman depth profile was
collected with the lid off just before fixing in formaldehyde. 785 or 633 nm lasers and
a x50 long working distance (LWD) objective (Olympus, N.A. 0.50) was used for all
intact skin measurements. Collection times varied from 3x50 s per point to 1x60 s per
point with total map times ranging from 120 minutes to 44 minutes. Typically three
profiles were collected from three random locations on each skin sample.
Tissue sections
Data from tissue sections were collected using 532, 633 and 780 nm lasers and a 50x
LWD objective. A 50-µm pinhole aperture was used for most of the data except for
occasional thin sections (10 µm) which often benefitted from a 25-µm pinhole aperture.
Collection times varied from a single 30 s exposure to 5x60 s exposures depending
on sample, substrate and laser. For normal skin samples, spectra were collected from
random points on each of the tissue layers: SC, epidermis and dermis. These layers
were easy to identify on white light images and then confirmed from the adjacent H&E
stained sections. On average, 5-10 spectra were collected from each layer of 2 to 3
sections of three samples. For melanoma samples, location of every sample point was
recorded on the white light image of the sample area. These points were then compared
to adjacent H&E stained sections to determine the corresponding tissue type/layer (e.g.
tumourous or normal looking, melanoma invaded versus non invaded dermal compo-
nents). Melanoma samples were divided into areas of different categories (Chapter 6)
with a minimum of 30 spectra collected from each area.
3.2.3 Raman instruments
Instrument 1: Thermo DXR Raman Microscope equipped with a 532 nm diode laser,
a 633 nm HeNe laser and 780 nm diode laser. Spectral resolution was 6 cm-1 for each
laser setup.
Instrument 2 (EIP Loan Pool): Renishaw InVia Raman Microscope equipped with
a 785 nm diode laser. Spectrometer aperture was set to 64 µm. The grating was 1200
lines/mm producing a reported maximum spectral resolution of up to 2 cm-1.
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3.2.4 Processing and Analysis of Raman data
Substrate subtraction, fluorescence correction and peak position measurements were
done on OMNIC and TQ Analyst (Thermo, U.S.A.). Substrate spectra were sub-
tracted from almost 90% of the sample spectra collected from tissue sections on glass
and quartz. Polynomials were subtracted from all spectra collected with the 633 nm
laser (Chapter 5, Section 5.2.2) to correct for baseline distortions. Degree of the polyno-
mial used varied from 3 to 6. Peak positions were measured as the position of maximum
height of a peak within a defined range (e.g. Max height in the range 1520-1360 cm-1
gives Amide II position.).
Unscrambler X (CAMO, Sweden) was used for the MVA methods Cluster Analysis
(CA), Principle Component Analysis (PCA) and Linear Discriminant Analysis (LDA).
The data were first baseline corrected and Unit Vector Normalised (UVN). Wards
method of clustering was used for CA. This method computes the difference between
(i) each sample in a group and (ii) between each sample to the groups centroid. The
parameters for PCA setups varied. Every PCA was setup with a minimum of 12 or-
thogonal variables depending on the spectral region used, where the number of PCs
chosen for each setup described >99% of the variation. All LDA models were setup
over the full spectral range. In each LDA, five random spectra from the data set were
left out of the training models at each run. Each set of five -unlabelled- random spectra
were tested against the corresponding training model until 20 such spectra were tested.
Model sensitivity and specificity were calculated by comparing predicted class to the
official class obtained through H&E staining.
Peak height measurements were done on OriginPro (OriginLab), TQAnalyst (Thermo,
U.S.A.) and WIRE (Renishaw, UK). Measurement of Phenylalanine intensity was done
on OriginPro. Spectra were normalised to Amide I, one peak was fitted to a fixed
position of 1002 cm-1, and height was measured from the baseline. Signal loss versus
depth for intact skin was presented as the percentage loss from the maximum intensity
point (Chapter 4). Height measurements of the high wavenumber region (3200-2600
cm-1) of tissue sections were performed on TQAnalyst. WIRE or OriginPro was used
for intact skins. For tissue sections, the height of peaks at the fixed locations of 2930,
2880 and 2840 cm-1 were measured from the baseline. Charts that track the protein
to lipid content in sectioned skin layers (Chapter 5, Section 5.2.1) use these measures.
For intact skins, 5 peaks were fitted to this band (fixed centres at 3047, 2980, 2930,
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2880 and 2840 cm-1). Lipid profiles through intact skin layers (Chapter 5, Section
5.2.2) use the intensities of these component bands. OriginPro was used to measure
the intensity of the Tryptophan doublet (Chapter 6, Section 6.2.3). This was done by
fitting two peaks with fixed centres representing the 1360 and 1340 cm-1 peaks to the
first derivative spectra.
Chapter 4
Raman Spectroscopy methods
4.1 Introduction
Comprehensive guides for using RS on skin tissues are not available. Many sample
preparation details such as preferred substrates or tissue preservation methods are
passed on within research groups as know-how. This is not altogether unexpected as
many of the tissue preparation methods are sample and application specific. For exam-
ple, dewaxing medium and times are not the same across samples or groups. Dewaxing
efficiency can be different on even tissues of the same type: brain tissue containing tu-
mour retains more wax than normal brain tissue with the identical dewaxing protocol
[Fullwood et al. 2014]. It is important to understand the effects these procedures have
on Raman signatures because research using a very wide-range of protocols are referred
to for the assignment and interpretation of peaks. It is also often much easier to make
changes to the sampling aspects in order to make data collection more straightforward
instead of extensive data processing afterwards. Whilst the following results chapters
deal with collected information, this chapter outlines the effects of some skin sampling
methods on data collection and processing.
4.2 Results
4.2.1 Backing substrates for tissue sections
All HSEs in this thesis were constructed using DED scaffolds made with excess skin
from surgeries or cadaveric skin. The use of these scaffolds means either a reliance
on hospitals which can be infrequent/unreliable or that great expenses are amassed
buying cadaveric skin from the euroskin bank. It restricts the number and size of HSEs
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produced and make the samples valuable. This often constrains the thickness to which
samples may be practically sectioned (<20 µm). Thin sections are practicable also, be-
cause it keeps Xylene washes to manageable time-scales for wax-embedded samples and
allows cryo-embedded samples to dry more uniformly. At unit thicknesses of 20 µm or
less, it is important that backing substrates for the sections do not have intense Raman
signals that will interfere with tissue signals. Figure 4.1 shows the Raman spectra of
some commonly used substrates across three wavelengths.
Several substrates produce Raman bands in regions overlapping tissue peaks, Table
4.1. CaF2 and MgF2 slides seem ideal as: i. their respective peaks at 320 and 405 cm
-1
can easily be truncated with no effect to the integrity of tissue data and ii. the peaks
are consistent for all wavelengths. Quartz slides have a particular signature that is
also consistent for all three wavelengths but it spans across a large spectral range from
around 900 to 200 cm-1 and overlaps tissue regions. Stainless steel slides by comparison
do not feature prominent bands but the largest baseline offset is observed with these
slides. Glass slides produce intense and broad bands that interfere with large portions
of tissue signals with all wavelengths. This makes substrate choice a limiting factor for
the Raman analysis of tissue sections. The extent of this limitation will theoretically
be minimal as long as tissue thickness exceeds the axial resolution of the setup: either
by increasing section thickness or by using higher N.A. objectives. Axial resolution of
a typical setup with 50x lwd objective often used in this thesis is shown in Figure 4.2.
Where depth of collection volume at any given point is approximately 20 µm. This vol-
ume is reported to be 7.5 µm with a 50x objective and 25-µm pinhole aperture. For the
50x objective, tissue thicknesses as low as 10 µm may therefore be supported without
substrate interference. But this does not always hold true. There are two factors to
note. In the first instance, skin tissue is more similar to fabric than to opaque matter.
Scattering effects often make substrates raman visible. Secondly, the SC, epidermis
and dermis are structurally different with regards density of packing. Spectra from the
keratinized SC layers may not show any signs of substrate backgrounds even at <10µm
thickness, whereas it is difficult to eliminate substrate background from the epidermis
and dermis at the same thickness. This difference between the layers also cause them
to dry at different rates leading to a rough surface topography.
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Figure 4.1: Raman spectra of common substrates for tissue sections using 532 (top),
633 (middle) and 780 (bottom) nm excitation. The measurements were taken off clean
substrates and using identical collection parameters for each laser wavelength (25 s,
two accumulations). The substrate spectra are offset to the Raman spectrum of a DED
cryo section to highlight overlapping regions.
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(a) (b)
Figure 4.2: Axial resolution of the system setup used for intact skin profiling (50x
lwd objective (N.A.0.50), 50 µm-pinhole aperture). The resolution was measured by
profiling 25µm above and below a Si surface. The 520 cm-1 peak was tracked to
determine the full width at half maximum (FWHM). (a) 3D profile of Si surface versus
depth. (b) Intensity of the 520 cm-1 Si peak plotted against depth. The FWHM is
measured as 20 µm. Actual/real axial resolution in skin will not be exactly the same
since laser attenuation is material dependent.
4.2.2 Choice of excitation wavelength
Restrictions that backing substrates pose depend on the excitation wavelength chosen
for the experiment. One can be chosen that gives little interference with a cheaper
substrate versus one that gives no interference but is expensive as long as: (i) the
substrate signals can be successfully subtracted from tissue signals or (ii) we have several
laser options. Figure 4.3 compares spectra with substrate backgrounds and after the
backgrounds have been subtracted. This method is found to work well approximately
60% of the time. Choice of substrate is then sufficiently large as long as any laser can be
used: if tissue spectra are independent of excitation wavelength. This is also important
because research is published using RS on skin tissues using a variety of lasers such as
532 [Talari et al. 2015, Downes and Elfick 2010], 660 [Tfaili et al. 2012, Nguyen et al.
2012] to 1064 nm [Edwards, Williams, and Barry 1995, Barry, Edwards, and Williams
1992]. Peak assignments are made from papers using any number of these options.
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With identical collection parameters, Figure 4.4 shows that strong tissue signals can be
obtained with wavelengths 532, 633 and 780 nm. But they differ in the amount signal
processing required. For example, 633 nm excitation nearly always required some level
of fluorescence correction. 532 nm excitation rarely required any processing but the
high wavenumber region between 3400-2600 cm-1 often saturated for up to 70% of SC
spectra. With regards repeatability, 532 and 780 nm were the most consistent across
all layers of skin tissues. The correction protocol per tissue layer differed much more
using 633 nm excitation.
Choice of laser becomes more important for intact skin measurements. The structure
and composition of skin layers vary with depth. It also contains light absorbing com-
pounds such as melanin. Shorter wavelengths scatter much more efficiently through
this densely packed fabric, resulting in high attenuation: depth of penetration varies
greatly with different wavelengths. In published works, signal loss due to physical pro-
cesses has been measured using the Phenylalanine peak at 1002 cm-1 [Yu et al. 2013]
or the Amide II band intensity at 1443 cm-1 [Tfaili et al. 2012]. This is likely because
these peaks stand alone and are easily isolated. Figure 4.6 shows signal loss in skin
measured against depth using Phenylalanine for 633 and 785 nm excitation. At 76µm
depth, 20% of the signal is retained with the 633 nm laser, and up to 50% for the 785
nm laser. In fact, the use of Phenylalanine as a reference point for measuring signal
loss is questionable. At 1002 cm-1, the peak represents v(C-C) ring vibrations [Talari
et al. 2015] which are abundant in keratins. Keratins are found at much greater con-
centrations in the stratified layers of skin tissues such as the SC (Chapter 6). And so,
a Phenylalanine gradient is observed in even sections of tissue, Figure 4.8. On tissue
sections, the intensity of this peak reduces by at least 50-100% between the SC and
epidermis and up to 200-250% between the SC and dermis. The Amide II band inten-
sity too is found to vary in layers (Figure 4.8). Signal loss for either of these peaks is
unlikely to follow a steady gradient throughout all the layers in intact skin.
Apart from signal loss, in this work, NIR excitation produced good SNR for the fin-
gerprint region, Figure 4.5, and required very little processing post-collection. But
for 780 nm there was heavy contribution from the objective lenses that could not be
subtracted.
4.2.3 Effects of sample preparation methods
In this thesis, apart from fresh intact samples, tissues were fixed in 3.7% formaldehyde
and processed for sectioning using two different methods: cryo-embedding and wax-
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Figure 4.3: Effectiveness of removing quartz and glass substrate contributions post-
collection. Unless successfully removed (bottom); quartz can mask a subtle and often
underused region between 850-750 cm-1 assigned to nucleic acid residues of DNA and
RNA, whereas glass can mask the 1200-1000 cm-1 region used for lipid phase analysis.
CHAPTER 4. RAMAN SPECTROSCOPY METHODS 49
3000 2500 2000 1500 1000 500
0.0
0.5
1.0
 532nm
 633nm
 780nm
In
te
ns
ity
 (a
.u
.)
Wavenumber (cm-1)
(a)
3000 2500 2000 1500 1000 500
0.0
0.5
1.0  532nm
 633nm
 780nm
In
te
ns
ity
 (a
.u
.)
Wavenumber (cm-1)
(b)
Figure 4.4: Comparison of the Raman spectrum of a DED cryo section with different
laser wavelengths. (a) Raw spectra with identical collection parameters (25 s, three
accumulations) and (b) Corrected spectra. 532 nm - baseline correction, 633 and 780
nm - 6th order fluorescence correction followed by baseline correction. The spectra
were normalised to the high wavenumber region.
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Figure 4.5: Comparison of the Raman spectra from the surface of intact skin tissues
with different laser wavelengths. (a) Raw spectra in the region 1800-500 cm-1 and (b)
Corrected spectra. 633 and 780 nm - 6th order fluorescence correction and baseline
correction, 785 nm - baseline correction.
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embedding. Fixation and processing has minor effects on the structures of skin tissues
(Chapter 5). Aside from effects on the biochemical integrity of the sample, each method
has separate advantages and disadvantages for Raman analysis in terms of practicality.
Both methods require the sample to be embedded in a conserving/protective medium
that can lead to artifacts. These can contribute to the spectroscopic signature. Cryo
embedding involves the use of O.C.T. but this only enwraps the sample. As it does
not diffuse through the tissues like wax, it is often an easier choice. The exception is
CaF2, MgF2 and quartz slides where the wash protocols had to be changed to prevent
the sample from sliding off during their submersion in PBS. Wash times were kept to
<1 minutes and the number of cycles increased. Wax removal from these slides also
had to be modified to prevent tissue slippage. In this case, sections on CaF2, MgF2
and quartz slides had to be baked at 60C before Xylene washes (in some cases tis-
sues slipped off quartz despite baking + reduced wash cycles). For signal quality, cryo
sections showed higher SNR compared to wax embedded sections under identical collec-
tion parameters, Figure 4.7. The spectral features were more defined in frozen samples.
Figure 4.6: Laser attenuation in fresh intact skin tissues plotted against depth for 633
and 785 nm excitation. The signal loss is measured as a percentage loss from the
intensity of the Phenylalanine peak at 1002 cm-1 at the surface, down to 80 µm and
100 µm depth.
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Figure 4.7: Averaged Raman spectrum of wax embedded and cryo embedded DED
samples. Collection parameters were kept identical (30 s, three exposures). Spectra
with higher SNR and more defined features are collected in shorter times for cryo
sectioned samples.
The main problem faced in this work was the removal of wax from wax embedded
samples. Despite following an established protocol [Mian 2015], it is to be noted that
Xylene washes were not very successful in removing all the wax from samples on any of
the substrates. This was likely a user-error as it is a method used often and with very
good outcomes. Here, the wax peaks were instead removed digitally, post-collection
(Figure 4.9). Whilst the approach was generally successful, many of the wax peak
positions are equivalent to positions observed for tissue lipids (Chapter 6). Notably,
there is also suggestion that wax embedding and the subsequent processing steps may
remove lipid components of skin layers that are structurally similar to wax [Ali et al.
2013b].
4.3 Discussion
Various practical aspects of sample presentation for Raman analyses is given in this
chapter. The purpose was three-fold: (i) make data collection easier through changes to
sample handling (e.g. increase thickness of sections to avoid substrate subtraction), (ii)
consider some instrument-specific conditions (e.g. minimum time for depth profiling)
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Figure 4.8: Peak intensity of Phenylalanine (left) and Amide II (right) measured from
cryo sectioned HSEs plotted against layer. The intensity gradient decreases in the
direction from the SC toward the epidermis and dermis. The spectra were normalised
to the high wavenumber region and intensities were measured against baseline offset.
and (iii) detail post-collection necessities (e.g. ease of fluorescence corrections).
The thickness to which skin samples need to be sectioned for Raman analysis is an
important consideration. Samples used in this thesis tended to be 1.5-2 cm2 in size.
Sections needed to be kept thin so as not to waste samples but thick enough to ensure
data collection and perhaps more importantly, data processing was not too difficult
or time consuming. Substrate signals can complicate interpretation of tissue spectra
if they overlap. Out of several common substrates, CaF2 and MgF2 are unparalleled
with regards the ease of excluding their Raman signals from that of tissue. Glass gener-
ally performed poorly, with quartz and stainless steel only outperforming glass because
their signals could be subtracted with greater success. However, the contrast is not so
clear when cost and ease of mounting is taken into account. CaF2 and MgF2 are expen-
sive substrates. While sections were mounted easily, washing off wax and O.C.T. was
difficult. Wax embedded sectioned needed to be baked at 60C before xylene washes to
prevent the sections from sliding off the slides (also true for quartz). The washing cycle
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Figure 4.9: Comparison of tissue signals from wax embedded (before and after wax
subtraction), and cryo sectioned HSE samples. Raman signature of wax includes peaks
at 1062, 1133, 1296 and 1441 cm-1. These peaks are also associated with v(C-C)
and δ(CH2, CH3) vibrations of skin tissue lipids [Barry, Edwards, and Williams 1992,
Lakshmi, Faola´in et al. 2005]. Subtracting a wax reference spectrum works well but
might cause some lipid information to be lost.
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needed to be adjusted to multiple <1 minute courses for cryo sections. Stainless steel
slides could have been a potential rival but also suffer from the same disadvantages.
Out of all the substrates, stainless steel slides were found to retain the most wax after
long xylene washes. CaF2 and quartz have previously been shown to retain more wax
than low-E slides by other groups [Fullwood et al. 2014]. Glass slides presented the
least concern about sample preparation methods because the wash cycles are already
established due to extensive use [Mian 2015]. Still, where available, quartz slides were
preferred for subsequent work. Quartz spectra are more easily subtracted from tissue
spectra compared to glass which overlaps tissue regions important for lipid phase anal-
ysis.
In fact, washing off O.C.T. was problematic for some slides but here, we found wax
removal was also problematic. Given the comparative nature of Raman work, any con-
cern over the purity of lipid data would still have been compensated if all samples used
in this work were wax embedded. As both cryo and wax embedded samples were used,
wax signals had to be digitally removed from nearly all wax embedded sample spectra
when comparing data. As for advantages: Wax embedded samples can be preserved for
much longer. But cryo sections produced spectra with much higher SNRs compared
to wax and O.C.T. was not found to contribute to their spectra. Cryo sections are
also thought to compare very well with fresh tissues [Shim and Wilson 1996], except
for some differences in the vibrational modes of proteins [Faola´in et al. 2005]. It is
suggested that re-hydration of cryo sections in PBS before Raman collection can even
further improve signal quality [Bonnier et al. 2012].
Substrate performance and tissue signal strength varied with different excitation wave-
lengths. There are clear differences in tissue spectra collected using VIS and NIR
wavelengths that stem from resonance effects and limitations to the efficiency of CCDs
[McCreery 2005]. For example, 488 nm is close to the resonance frequency of carotenoids
and is always more intense in lower VIS lasers [Hata et al. 2000]. Whilst the high
wavenumber region of tissue spectra between 3200-2600 cm-1 is less intense in the NIR
compared to VIS due to lower CCD quantum efficiency. This chapter was concerned
with the practical implications of using different lasers. Each laser provided spectra
with sufficiently high SNR for detailed analysis. Quartz, CaF2 and MgF2 were all good
substrates to use for all three lasers but stainless steel had intense baselines for all lasers.
For tissue sections on glass slides, glass fluorescence was found to overwhelm all biolog-
ical signals even under highly confocal collection modes for >633nm. This limited work
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with glass slides to VIS lasers. Apart from substrates, the lasers had a big difference
in signal processing required post collection. Little to no fluorescence is expected with
excitation wavelengths over 600 nm [Bonnier et al. 2011] but here, heavy corrections
were needed with 633 nm. This was more pronounced in intact skins. Whereas 785 and
532 nm often only needed baseline correction. Processing spectra from different lasers
and of different qualities is a big aspect of MVA; where it is critical to reduce variations
due to instrument/collection parameters (such as baseline offsets due to fluorescence)
in order to focus on biochemical differences.
There are few papers that detail in vivo Raman measurements on skin tissues [Gni-
adecka et al. 1998, Schallreuter et al. 1996, Barry, Edwards, and Williams 1992, Shim
and Wilson 1996]. Even fewer that deal with penetration to some tens of microns
depth that keep SNR high enough to perform analysis on fingerprint regions. These
include reports of profiles down to 48 [Chrit et al. 2005], 60 [Yu et al. 2013] and 85 µm
[Caspers et al. 1998]. The profile depths can be up to 200 µm when only looking at
the high wavenumber region for measuring water content [Caspers et al. 2001, Caspers,
Lucassen, and Puppels 2003]. Only one paper was found to assess penetration depth
in skin tissue (pig skin) by looking at the signal loss down to 36 µm [Tfaili et al. 2012].
Where signal loss was measured as a function of the Amide II band intensity at 1443
cm-1. For 633 nm excitation, the loss was nearly 100%, and approximately 80% for
785 nm excitation at the profile limit. Here, the signal loss we report is much lower:
approximately 90% loss for 633 nm and 50% loss for 785 nm at 80µm. This is not
wholly surprising as collection parameters (objective, laser power, exposure time) and
spectrum normalising methods were different. Collection time for each spectrum of the
depth profiles using the 633 nm laser were closer to 7 minutes compared to 20 seconds
in [Tfaili et al. 2012]. A likely reason for having so few papers detailing signal loss is
this: signal loss is both instrument specific and user specific. There also doesn’t appear
to be an established standard for normalising spectra for penetration studies. As well
as the Amide II band previously mentioned, the 2930cm-1 protein band [Chrit et al.
2005, Caspers et al. 2001] has been used for this purpose. And works that measure
penetration of chemicals into skin often measure this against keratin, assuming keratin
content is constant with depth [Bonnist et al. 2011a, Broding et al. 2011]. Many of
these bands have natural gradients in skin. In particular, keratin gradients are shown
to vary greatly from its expression in all suprabasal layers to only in higher suprabasal
layers with different HSE products and culture conditions [Boelsma et al. 2000]. This
was also true for HSE samples used in this thesis where we see a 50-100 % reduction
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in the intensity of the Phenylalanine peak at 1002 cm-1 between the SC and the viable
epidermis. Signal loss and penetration of chemicals would be best measured against
a peak that remains constant through all the skin layers. Without a constant, it is
difficult to determine whether: (i) the chemical concentration is decreasing while ker-
atin stays constant, or (ii) both the chemical and keratin is decreasing -but at different
rates. Despite detailed analysis of the spectra from skin layers (Chapter 5), we were
unable to find such a peak. Where even the Amide II band was seen to vary between
layers of cryo sections of skin tissues. The Amide II band is even shown to be affected
by the hydration state of tissues. Its intensity increases relative to the Amide I band
as fresh tissues dry out [Shim and Wilson 1996]. Interpreting data that is tracking
ratios needs to be done carefully unless one of the peaks can be isolated and measured
independently.
4.4 Conclusions
The effects of several sample preparation and presentation methods are explained in
this chapter. Substrates and sample preservation chemicals are found to interfere with
signals from tissues. Either of these may be prevented by choosing suitable substrates
and laser wavelengths or by digital removal post data acquisition. However, avoiding all
interference is very difficult because of either the specific application, cost-limitations
or the availability of suitable materials. Point in fact, data for this thesis was collected
from samples on different substrates, using different wavelengths and preserved with
different chemicals. It would be difficult to carry out the necessary analysis in subse-
quent chapters on spectral regions not affected by these user-dependent variables (there
is very little). Instead, the approach has been to study their effects and recognise their
contribution while interpreting tissue signals.
Chapter 5
Normal Skin Tissue
5.1 Introduction
Non destructive tissue characterisation methods are not what they should be. Tech-
niques used to describe tissue layers well are invasive, rely on external contrast agents,
render the sample non viable or have limited depth penetration [Georgakoudi et al.
2008]. This chapter explores the use Raman spectroscopy to observe biochemical and
structural information in engineered human skin equivalents (HSEs).
HSEs have clinical relevance. The European Commissions Cosmetics Directive has
recently constrained the testing and marketing of finished cosmetic products and in-
gredients on animals. Under the REACH legislation, testing of cosmetic products on
animals are prohibited where alternatives are available and the sale of products newly
tested on animals are banned within Europe regardless of the country the testing was
carried out in. This has motivated increasing research into HSEs as an alternative to
perform safety tests on a wide range of products including cosmetics and pharmaceu-
tical formulations. Their production requires sterile conditions making in vivo access
by standard biological techniques difficult. Monitoring and evaluating the effects of
changes in process conditions or tracking the tested formulations are mostly limited
to in vitro observations. The HSEs are cultured, sacrificed and fixed prior to analysis.
This approach has several disadvantages. The fixation steps may lead to artifacts. But
in particular, monitoring a parameter at different time points limits the frequency with
which observations are made as it requires multiple samples to be made and sacrificed.
Accessing and monitoring the HSE products in situ under normal growth conditions
will be a major advantage to determine the impact of process parameters on living
58
CHAPTER 5. NORMAL SKIN TISSUE 59
systems.
3000 2500 2000 1500 1000 500
0.0
0.5
1.0
In
te
ns
ity
 (a
.u
.)
Wavenumber (cm-1)
 SC
 epidermis
 dermis
Figure 5.1: Raman spectra of the SC, epidermis and dermis of an engineered skin
model.
5.2 Results
5.2.1 Layer characterisation
Skin is a highly heterogeneous tissue composed of layers which are dissimilar in struc-
ture, molecular composition and function. The epidermis is comprised of multiple levels
starting with the SC at the air/skin interface down to the basal layer closest to the
basement membrane. The basal layer sees a continuous proliferation of cells that con-
stantly move upward and become the anuclear, keratinized cells of the SC where they
are routinely shed (Chapter 1). At this top layer, the anucleated cells are embedded
in a matrix of lipid-by-layers, which act as a water sealant. This forms the primary
barrier to the external environment with the keratinocytes also acting as immunomod-
ulators. The epidermis is supported by the dermis which provides mechanical strength
to the skin and regulates internal temperature. Each of these layers may be altered
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in different ways under disease states [Knudsen, Edwards, Williams, and Barry 1995,
Hata et al. 2000] or through the application of cosmetic and drug formulations [Tfayli
et al. 2012, Bonnist et al. 2011b, Broding et al. 2011]. There is a need for better ways
of monitoring such alterations. This section describes how Raman data may be used
to identify and characterise some aspects of these skin layers.
5.2.1.1 Human skin equivalents
Resolving skin layers from lipid-to-protein concentrations: υ(CH) vibrations
of lipids and proteins are represented in the region 3200-2600 cm-1 (Figure 5.2). The
region has prominent features that are protein specific at 2980 and 2930 cm-1 represent-
ing υ(CH3) vibrations; and bands at 2880 and 2840 cm
-1 that originate from υ(CH2)
asymmetric and symmetric vibrations of lipids [Ali et al. 2013b, Gniadecka et al. 1998].
The 2880 and 2840 cm-1 lipid band intensities decrease relative to the main protein
band at 2930 cm-1 as skin is profiled from the surface. Figure 5.2d charts the ratios
I2930/I2880 and I2930/I2840 against the skin layer from which they stem from. The charts
indicate a gradient from lipid-rich to protein-rich in the direction of the SC/epidermis
to the dermis. The greatest change is in I2930/I2840 which increases by at least three-
fold between the epidermis and the dermis.
There are two other major bands of lipids at 1438 and 1300 cm-1 representing δ(CH2)
vibrations [Talari et al. 2015]. The peak at 1438 cm-1 is masked by Amide II, but a
slight decrease in the 1300 cm-1 peak is observed between the SC and epidermis with
most day 14 HSEs that formed a mature SC layer (Figure 5.2b). Apart from the high
wavenumber lipids, the dermal layer may also be identified through three spectral fea-
tures related to collagen. The 2980 cm-1 shoulder band of protein increases as the
collection volume reaches the dermal component, Figure 5.3b. This shoulder band is a
prominent feature of collagen [Nijssen et al. 2002]. Secondly: the 1267 and 1248 cm-1
bands increase markedly relative to the 1400-1300 cm-1 band of Amide III, Figure 5.3c.
These two represent the υ(C-N) and δ(N-H) vibrations of collagen at 1267 cm-1 and
1248 cm-1 [Talari et al. 2015]. Thirdly: the 920 and 855 cm-1 peaks represent vibrations
of the amino acid side chains proline and hydroxyproline and the υ(C-C) backbone vi-
brations of collagen [Caspers et al. 1998, Talari et al. 2015]. These amino acids makeup
nearly a quarter of those found in collagen and the bands representing them show a
clear and marked increase in the dermis, Figure 5.3d. Observing these three features of
collagen may be used as a marker for the boundary between the epidermal and dermal
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layers in skin tissues.
Ascertaining the lipid phases of the Stratum Corneum: The 1200-1000 cm-1
region contains information on the order of lateral packing of the acyl chains. Where
peaks at 1130, 1080 and 1060 cm-1 represent the υ(C-C) vibrations of trans, ran-
dom(gauche) and trans lipids respectively [Chrit et al. 2005, Gniadecka et al. 1998].
These peaks are characteristic of the Raman spectrum of ceramide which is found ex-
tensively in the lipids of the SC [Wegener et al. 1996, Wegener et al. 1997]. In trans
conformation the lipids are highly ordered and the intermolecular structure is stable.
In HSEs with well-formed SC layers, the lipids were mostly in either a predominantly
trans phase or had a mixture of trans and gauche lipids, Figure 5.4. For most cases,
the 1080 cm-1 gauche peak increased relative to the trans peaks as the collection vol-
ume moved into the epidermal layer. This suggests the lipids of the viable epidermis
adopting a combination of trans and gauche configuration. This region of lipids was
found to be sample specific and showed large regional variations, Figure 5.4.
Conformational differences in proteins of the SC, epidermis and dermis: A
noticeable feature observed in the high wavenumber region is a shift of the 2930 cm-1
band of proteins to higher wave numbers in dermis spectra (Figure 5.5). It has been
previously suggested that this shift likely represents a highly folded and compact pro-
tein structure in the SC and epidermis versus a more unfolded structure in the dermis
[Gniadecka et al. 1998]. And that the looser form in the dermis exposes and allows
the amino acid side chains to interact and bond with water [Verma and Wallach 1977].
The band maxima at a higher wavenumber for the SC and epidermis therefore describe
instead a form that is probably hydrophobic to its environment.
There are several Raman vibrational bands in the form of the amide regions which
are sensitive to the conformational state of proteins. These bands represent various
aspects of the peptide linkage that form the protein macromolecules, Figure 5.6. The
proteins’ shape in space depends upon the secondary and tertiary structures of the
chain, where the secondary structure is formed by folding of the primary chain so as to
maximise the number of hydrogen bonds formed between different parts of the chain.
There is an interdependency between the hydrogen bonding state of the peptide bonds
and the frequency of the amide vibrations [Walsh et al. 2003, Qian, Mirkin, and Krimm
1999]. Because of this, the amount of secondary structures of proteins or any changes
thereof may be detected in the amide bands, Figure 5.6.
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Figure 5.2: Prominent spectral markers of lipids: (a,b) Raman spectrum of SC, epider-
mis and dermis from a cryo-embeded day 14 HSE in regions. 3200-2600 cm-1 (a) and
1510-1140 cm-1 (b). The annotations highlight peaks associated with overall protein
content (2930 cm-1), and lipid content (2880, 2840, 1438 and 1300 cm-1). (c) H&E
stained section of a day 14 HSE. (d) Charts following the ratios I2930/2880 and I2930/2840
in the SC, epidermis (E) and dermis (D) of two cryo-embeded day 14 HSEs. The peaks
intensities were measured as the height from baseline offset for the fixed locations of
2930, 2880 and 2840 cm-1. For both, there is a gradient from high relative lipids to
high relative proteins in the direction from SC to dermis.
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Figure 5.3: Prominent spectral markers of collagen: (a) H&E stained section of a day
14 HSE. (b) 2980 cm-1 shoulder band of υ(CH3) vibrations. (c) 1267 and 1248 cm
-1
peaks of υ(C-N) and δ(N-H) vibrations (Amide III). (d) 920 and 855 cm-1 peaks of
υ(C-C) vibrations for proline and hydroxyproline. There is an abrupt change in all of
these bands as the collection volume moves into the dermal component.
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Figure 5.4: (a) H&E stained cryo section of day 14 HSE. (b) Raman spectrum of SC,
epidermis and dermis in the 1200-1000 cm-1 region of lipids. Prominent trans lipid peaks
in the SC decrease as gauche lipid peaks increase in the epidermis. (c) Raman spectrum
of the SC at four random locations on the same cyro section. Relative trans/gauche
peak intensities vary across the same samples and between samples.
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Figure 5.5: Position of the 2930 cm-1 protein band for cryo embedded, day 14 HSE
samples across tissue layers. The band position moves by several wavenumbers in the
dermis.
The Amide I band in particular is considered to be highly sensitive to the secondary
structure of the protein backbone. Estimation of the percentage of secondary structures
and conformational alterations under different experimental conditions have shown
good correlation between X-Ray diffraction data and RS [Berjot, Marx, and Alix 1987].
The main contributor to the band is the υ(C=O) vibrations of the backbone structure
with minor contributions from the υ(C-N) and δ(N-H) vibrations. Amide I is seen to
broaden as the collection volume moves down into the dermis, Figure 5.7. This may
be attributed to the increased presence of collagen at 1666 and 1631 cm-1 [Gasior-
glogowska et al. 2010]. As well as broadening, a shift is observed in the band maxima
similar to that seen with the 2930 cm-1 band. The band may be decomposed into the
component Raman peaks for α-helical (1640, 1650-52 cm-1), unordered (1660 cm-1) and
β-sheet (1673 cm-1) forms [Berjot, Marx, and Alix 1987]. In the SC and epidermis, the
Amide I position suggests the presence of largely α-helical proteins. Large amounts
of keratin in this region may account for this. Whereas, in the dermis, an upshift
suggests that while some α-helix forms still remain, there is a much higher percentage
of unordered and β-sheet forms (Figure 5.7). The band maxima for the dermis more
closely resembles those seen in pure type I and IV collagen spectra [Nguyen et al. 2012].
The Amide II band largely represents δ(N-H) and υ(C-N) vibrations of proteins. The
band does not alter much between the epidermis and dermis. An occasional exception
CHAPTER 5. NORMAL SKIN TISSUE 66
is areas that are very high in lipids. A large increase of a component peak representing
vibrations of lipids at 1438 cm-1 results in a slight shift of the band in some lipid-rich
areas.
The Amide III band represents the υ(C-N) and δ(N-H) vibrations (Figure 5.7). In
contrast with the other Amide bands, large contributions from the protein side chain
vibrations in this band make it difficult to be conclusive about secondary structure.
Still, some limited conformational information may be extracted. Characteristic of α-
helical conformation is the 1267 cm-1 band, the 1248 cm-1 band represents an unordered
conformation [Gasior-glogowska et al. 2010] and β-sheet forms are represented at 1230
cm-1. Here too, the proportion of α-helix forms are greater than in the unordered and
β-sheet conformations in the epidermis and vice versa for the dermis. However; the
distribution of these forms varied within cryo embedded and between wax and cryo
embedded samples (section 5.2.2).
Apart from the H-bonds that help maintain the secondary and tertiary structures, a
more powerful covalent bond is formed in proteins that contain (-SH) groups. Namely;
disulphide bridges. Two peaks that represent υ(C-S) vibrations are observed at approx-
imately 640 and 620 cm-1. These peaks are striking in the spectrum of the SC and in
the epidermis (to a lower extent) but disappear in the dermis (Figure 5.8). They likely
arise from keratins which contain large amounts of Cysteine. The disulphide bridges
form keratin into a helical structure imparting a string like function to it.
5.2.1.2 Sampling and source variations
Distinct structural and compositional differences of skin layers impart different func-
tions to each layer. It is important that HSEs mimic these differences as they will
dictate the functional state of the composite. Testing products on HSEs that are simi-
lar to native human skin will ensure any data resulting from tests carried out on them
to be extended to real skin making them clinically relevant. This section describes how
closely Raman data of HSEs resemble those from native skin tissues and how dependent
layer information is on sampling methods.
Spectral fingerprints for native skins and engineered HSEs grown at the air-liquid in-
terface for 14 days differ in their lipid content. In native samples, I2930/I2880 shows
a more separate step-wise increase between both the SC and epidermis and the epi-
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of the peptide chain as the protein folds [Alberts et al. 2013].
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Figure 5.7: (a) H&E stained section of a cryo embedded day 14 HSE and (b) Raman
spectra from the Amide regions (1760-1140 cm-1). Amides I (c) and III (d) highlighting
differences between the SC, epidermis and dermis in cryo embedded HSE samples.
Amide I and III annotations show the protein conformations expected in the respective
peak positions.
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Figure 5.8: (left) H&E stained section of a day 14 HSE. (right) Raman spectrum of
SC, epidermis and dermis in the 800-400 cm-1 region. Peaks at 640 and 620 cm-1 rep-
resenting v(C-S) vibrations decrease and then mostly disappear in the dermis. Keratin
content is likely a big contributor to these peaks as it contains large amounts of cysteine.
dermis and dermis. 1300 cm-1 peak of lipids is also more defined in native skin SCs.
These lipid peaks in some cases even allowed a rough estimate on the location of the
SC/viable epidermis boundary (section 5.2.2). Other than this, the spectra from both
sources visually resemble each other very closely. In section 5.2.1.1, the spectra from
each sample were location-labelled based on H&E images (each spectrum was labelled
as SC, epidermis or dermis). And several spectral features believed to be indicative of
a particular layer were identified in the previous section using a small number of sam-
ples and visual observations. As the data set increases, Multivariate Analysis (MVA)
methods can in some instances provide more non-subjective measures. It can also allow
more of the data within the spectra to be employed in the analysis. This is particularly
useful in cases such as this where there otherwise appears to be very little change in
the spectra of native skin and engineered HSEs. Cluster Analysis (CA), groups like
observations on the basis of the variables defined (the XY data forming the spectrum).
The partition of data is unsupervised so it helps discover categories which are implicit
in the data themselves. Figure 5.9 shows CA results on a data set comprising of spec-
tra collected form two different layers (epidermis and dermis), and from tissue of two
different sources (native and engineered). Here all dermis spectra are assigned to a
single cluster, all epidermis spectra are assigned to a separate second cluster. The two
clusters separate for tissue layer, but are not indicative of tissue source.
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Principle Component Analysis (PCA) is a MVA method that helps visualise data.
Data is projected down to a lower dimensional space based on the highest variation.
The direction showing the largest variation is the Primary Component (PC1). Then
the direction of the second largest variation orthogonal to the first is described by the
second PC and so on. Where CA groups like observations, PCA re-expresses the data
as a sum of these PCs and groups like variations. It is a purely descriptive technique
that gives a view of the systemic variation in the data using fewer variables. In Fig-
ure 5.9, PCA was performed to reduce the data, same as used for CA, to a linear
combination of 7 orthogonal variables. The scores plots show the distribution of data
with respect to the PC it is describing. Here, PC2 is seen to cluster each layer sepa-
rately whereas PC4 describes a variation between native and engineered samples. This
PCA suggests that there is information contained in the data that allows the separa-
tion of both tissue layers, and source. But that the variation arising from compositional
differences extending from layers exceed the variation due to tissue source (PC2 >PC4).
In fact, performing PCA over a data set of several HSE samples that contain spec-
tra from: (i) three different skin regions (SC, epidermis and dermis), (ii) using two
different lasers (532, 633 nm), (iii) on three different substrates (glass, quartz and
CaF2) and (iv) that were preserved using two different methods (cryo and wax embed-
ding) shows that the bands used for layer identification cluster these layers separately
despite even sampling variations. The PCAs in Figure 5.10 were setup over the spectral
ranges 1760-1180 (Amide regions) and 985-600 cm-1. These regions were chosen as they
were sensitive to layer information and because they avoided some regions that show
high variation that are due solely to sampling methods, such as substrate and wax
interference (Chapter 4). For the amides PCA, PC2 separates the SC and epidermis
from dermis spectra. Loadings plot for this PC suggest that bandwidths of Amide I,
Amide II and collagen-related region of Amide III all contribute heavily to the sepa-
ration of the dermis. Separation of the SC from epidermis spectra was not as clear
cut. The lipid peak at 1300 cm-1 and bands at approximately 1576 cm-1 that represent
nucleic acid residues appear to have an effect on the minor barrier between the SC and
epidermis in PC4. 985-600 cm-1 region has little contribution from lipids, but contains
large amounts of information on nucleic and amino acid vibrations. This region also
gives good separation between the dermis and superficial layers of the skin, but more
importantly, in PC3, it describes a variation that clusters the SC and epidermis apart
form each other.
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Tentatively, the PCA results suggest that the spectral signatures are very layer-specific
and that fingerprint regions can identify the layers regardless of source or sampling
method. This is tested here with another MVA method: Linear Discriminant Analysis
(LDA). LDA is used for predicting classes of unknown samples by testing them against
a reference data set whose sample categories are known. Like PCA, this involves re-
ducing the dimensions of the data in directions where the variance is the greatest. But
unlike PCA, the search for variation in LDA is supervised by the reference data set:
the projection follows the direction that maximises class discrimination. This takes
into account the standard deviation within classes and the variation(s) is chosen that
projects samples of the same class close together but the means of each class far apart
from each other. Table 5.1 shows the results of a LDA model that was built with
epidermis and dermis spectra from both native and some HSE samples as a reference
set. Several epidermis and dermis spectra from both sources were then tested against
this model. The layer from which the spectrum was collected is predicted with 100%
accuracy.
Table 5.1: Results of LDA classification. The models first training set was built with
30 spectra (epidermis and dermis) from the same sample matrix used for PCA. Layer
assignments from 30 different spectra were removed and tested against this first training
model. The sets were then reversed. Initial training set of 30 was de-classed and tested
against the second training set built from the first test set of 30. In this way, all
60 spectra were run against the program. Prediction of layer from spectral features
is accurate with a model that includes 4 different HSE samples (two wax, two cryo)
despite sampling variations.
Predicted Epidermis Dermis
Actual
Epidermis 60 0
Dermis 0 60
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Figure 5.9: (a) CA results on native (HS) and engineered skin (HSE) samples. Despite
two different sources, information contained in Raman spectra separate skin layers
perfectly. (b) PCA results on the same data set used for CA. Scores plot highlights
two PCs that together describe variations that separate both tissue layers and source.
The biggest contributor to the separation of layers is Amide I and III (not shown).
Loadings for PC4 is too complex to identify narrow regions that are more sensitive to
source discrimination.
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Figure 5.10: PCA results on data from several HSE samples that were preserved using
two different methods (cryo and wax), sectioned onto three different substrates (CaF2,
quartz, glass) and collected using two different lasers (532 and 633 nm). The spectra
were all UV normalised before analysis. PCA was performed on the 1st derivative
spectra (to remove any baseline effects) and over the regions 1760-1140 cm-1 (a) and
985-600 cm-1 (b).
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5.2.2 In vivo property estimation
Reliance on ex situ methods for measurements of quality and maturation is limiting:
tissue fixation steps (i) can potentially alter microstructures. There are several fibrous
proteins found in skin, such as collagen, elastin and keratin, that are highly resis-
tant to acids, alkalis and temperature differentials. This is reflected in their ordered,
repetitive structure but such a rope-like organisation also means they can be stretched
and contracted. For example, keratin can double in length when soaked in water. The
stretching may not only affect mechanical properties but also bond lengths and in turn,
Raman signatures. This raises the practical question: how truly does Raman band as-
signments made through in vitro measurements match those from living systems? (ii)
do not allow for kinetic measurements. This is a major obstacle in the automation
and scale up of HSE growing processes that are in demand. Tissue culture processes
require extensive in-line controls as the growth characteristics of a given cell line may
differ significantly as bioreactors are scaled up even under identical process conditions.
This section describes how spectral fingerprints differ in hydrated intact samples vs
processed sections and how several spectral features identified in previous sections may
be used to monitor epithelial layer maturation on HSEs while still in culture.
Some differences in protein structure between intact and sectioned tissues:
A large shift is observed in the main protein band at 2930 cm-1 between the epider-
mis and dermis of sectioned tissues. This shift is more prominent in sectioned tissue
compared to intact skins, Table 5.2. This might be due to one or more of the tissue
processing steps of fixation. And it might be indicative of differences of protein confor-
mation in vivo versus in vitro.
The position and bandwidth of the Amide bands are found to differ between fresh
intact skin versus sections of processed skin. For intact, hydrated skin samples, the
Amide I band broadens in the dermis but does not shift to the same scale as seen in
sectioned tissues (Table 5.2). Difference in band maxima between the epidermis and
dermis is approximately 14 ±3 cm-1 in sectioned tissue compared to 5 ±2 cm-1 for
intact tissue. For sectioned tissues, it was hypothesised that the shift reflects a higher
percentage of epidermal proteins in α-helical form compared to more unordered and
β-sheet forms in the dermis. Along this line of reasoning, a high percent of dermal
proteins in unprocessed intact skin are in α-helical form. In Amide III, β-sheet and un-
ordered protein peak intensities were high in the dermis of sectioned tissue. The band
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shape is different for intact skin: The relative intensities for 1267, 1248 and 1230 cm-1
peaks of collagen conformation are instead suggestive of more α-helical forms in intact
skin. A downshift from α-helical to β-sheet may be associated with the stretching or re-
organisation of the hydrogen bonded network of collagen [Gasior-glogowska et al. 2010].
And has been reported in collagen fibres under uniaxial stress [Gasior-glogowska et al.
2010]. It is possible that fixing and dehydration of the skin tissue causes a remodelling
of the collagen network causing dermal proteins to downshift from α-helical to β-sheet.
Amide II position is also of possible note. The position of the band maxima did not
alter much between epidermis and dermis of tissue sections. The difference was minor
with a shift of 2 ±1 cm-1 between the means but a lot of inner and between sample
variation was observed. In contrast to this, the position of this band in the dermis of
intact tissue changed to a higher wavenumber, the shift was 4 ±1 cm-1 between the
means of each layer, Table 5.2. The difference in Amide positions is also observed be-
tween spectra obtained from hydrated DED and from the same DED after it dried out
for 24-hours, Figure 5.11.
Table 5.2: Differences in protein band positions between processed and intact skin
tissues.
Layer 2930cm-1 position Amide I position Amide II position
Cryo
epidermis 2930.4 (2925.1-2931.4) 1654.3 (1651.9-1657.2) 1447.0 (1444.7-1448.0)
dermis 2939.1 (2927.7-2940.6) 1668.1 (1666.3-1670.7) 1448.8 (1446.7-1450.8)
Wax
epidermis 2931.1 (2931.0-2933.0) 1653.8 (1652.9-1655.1) 1448.2 (1447.3-1448.6)
dermis 2938.2 (2937.0-2939.1) 1666.4 (1664.9-1668.0) 1449.7 (1449.3-1451.0)
Intact
epidermis 2933.8* (2931.1-2934.8) 1653.9 (1653.2-1654.8) 1448.0 (1446.9-1448.3)
dermis 2938.5 (2938.1-2939.4) 1656.1* (1654.9-1657.0) 1451.6* (1450.0-1452.5)
Surface lipid profiles of intact HSEs: Lipid profiles of intact skin tissues closely
match the trend seen in tissue sections. Figure 5.13 shows a depth profile from intact
native skin to a depth of 80 µm. The region 3200-2600 cm-1 is deconvoluted into its
component peaks of proteins and lipids (2980, 2930, 2880 and 2840 cm-1) and the ra-
tios I2930/I2880 and I2930/I2840 are charted versus depth. In both cases, they reveal a
lipid-rich area that remains largely constant that is tens of microns thick (region A).
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Figure 5.11: Differences in protein vibrations between intact and processed skin tissue
dermis. (a) 1st derivative spectra for Amide I (1760-1160 cm-1) and (b) 2nd derivative
spectra for 1015-700 cm-1 regions. The spectra were unit vector normalised. Amide I
maxima shifts to a higher wavenumber after DED is processed (mixed conformations
to predominantly β-sheet). Proline and hydroxyproline vibrations vibrations (920 and
855 cm-1) are also much higher relative to Phenylalanine (1002 cm-1) when DED is
processed. Changes are likely due to effects of hydration on dermis structure.
The protein content is seen to increase steadily from this point on (Region B) before
it reaches a protein dominant plateau (region C). These regions correlate well to the
measured thickness of the SC (A), epidermis (B) and dermis (C) that were obtained
using the H&E images of the same sample. The boundaries are readily identifiable in
this instance, where SC ends at 12 µm, and dermis begins at approximately 70 µm.
However, lipid profiles from engineered HSEs were not so easily expressed. This is
partly due to most of these samples not having SCs that were as well established as
those seen in native skin samples. The 2880 and 2840 cm-1 lipid peak intensities were
not as intense and a transition from Region A to Region B was not always observed.
Instead, there was a sudden and sharp increase from an unbroken Region A/B (SC
and epidermis) to Region C (dermis). HSEs also showed a lot more regional variation.
For example, in some samples, optical microscope images of the HSE surface revealed
features which differed in morphology and height. These were labelled as areas rep-
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resentative of an abundant smoother surface (position A) and of pockets with a more
compact almost aggregate like appearance (position B). Random locations that sup-
port both these areas were profiled. Figure 5.12. At position (A), intense peaks in the
2880, 1438 and 1300 cm-1 bands characteristic of lipids are absent. Likely indicating
a lipid-rich matrix similar did not form in this location. The spectra share a much
greater likeness to the Raman spectra of the epidermis compared to the SC. Having no
prominent peaks of trans-phase lipids at 1060 cm-1 makes it likely that the region has
limited barrier properties. At position (B), more prominent bands are observed at 2880
and 1300 cm-1. The spectra in this region show peaks indicative of both trans-phase
(1060 cm-1) and unordered (1080 cm-1) lipids. Presence of these peaks suggest a strat-
ified layer that bear a close resemblance to a SC. This points to regional variations in
lipid concentrations across the surface of some HSEs even after 14 days at the air/liquid
interface. This might be due to culture conditions or under-maturation of the HSE.
Maturation of the SC is in fact observed very well in samples that were grown for 7 days
at the air-liquid interface versus those grown for 14 days. Figure 5.14 shows surface
spectra from a day 7 HSE and a well-established day 14 HSE. In the 1200-1000 cm-1
region, a much larger amount of gauche lipids are found in day 7 compared to day 14.
Estimating thickness of the epidermal layer of some HSEs: Epidermis thick-
ness from a day 7 HSE is estimated non invasively using two different spectral regions in
Figure 5.15. Tracking two markers of collagen indicated the epidermis is approximately
50 µm thick. In contrast to this, the thickness of the epidermis could not be estimated
for many of the day 14 HSEs used in this study. This was because the epidermis thick-
ness exceeded the profiling depth. An example of this can be seen in Figure 5.16 where
the dermal component is not reached even at 90 µm depth. And Figure 5.16 examples
a profile from native skin. Approximations were easier in native skins as, for the two
types of samples used here, the epidermis thickness was less than in-house grown HSEs.
In fact, a cross-sectional 2D plane of intact native skin was mapped successfully to
visualise tissue layers. The grid in Figure 5.17 represents a Raman depth slice tracking
the increase in the intensity of the area under 1267-1248 cm-1 band to the 1400-1300
cm-1 band. At approximately 60 µm depth, I1267-1248/I1400-1300 increases suddenly and
sharply indicating a large increase of collagen in the collection volume. This pinpoints
the location of the epidermal/dermal barrier.
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Figure 5.12: Variations in the surface lipids of some HSE samples. Intact skin raman
spectra from (a) High-wavenumber region lipids (3200-2600 cm-1) and (b) fingerprint
lipids. Lipid composition is different in two separate regions of the same HSE sample.
Compared to position B, lipid content appears to be much lower in position A. A full
lipid bi-layer has not formed on the entire HSE surface.
5.3 Discussion
In this study Raman measurements were carried out on intact skin tissue to study the
molecular conformation of compounds in their natural micro environment and to see
how this correlated with measurement obtained from processed tissue. It was shown
that it is possible to obtain information on the lipid and protein structures and use
them to separate the skin layers.
Lipids: In native skin and HSEs, measuring the lipid packing within layers is im-
portant. It means HSEs can be compared to native skin with regards whether or not
a similar barrier is formed and maintained. HSEs which can mimic this property are
more useful in the pharmaceutical and cosmetics industries as the way in which some
topically applied drug or cosmetic formulations access deeper tissue layers is by alter-
ing the lipid packing from trans-gel to liquid-crystal [Fo¨rster et al. 2012]. Resolving
both the tissue layers and change in lipid packing after application may allow more de-
tailed investigations into how these formulations interact with the skin layers [Bonnist
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Figure 5.13: Lipid profile of an intact native skin sample. (a,b) Raman spectra of
the highwavenumber region (3200-2600 cm-1) at different depths. (c,d) I2930/I2880 and
I2930/I2840 tracking protein-to-lipid ratio of intact skin down to 80µm below the surface.
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Figure 5.14: Surface lipids of intact HSEs in culture. H&E stained section of day 7 (a)
and day 14 (b) HSEs. (c) Raman spectra from the surface down to 24 µm below the
surface of a day 7 HSE. (d,e) Raman spectra from the surface down to 24 and 16 µm
below the surface of a day 14 HSE (positions A and B from Figure 5.12 respectively).
The profile collected at position A contains more gauche lipids compared to a second
position B. The lipid layer has not matured in position A as it bears a much closer
resemblance to the lipid phase spectra of day 7 HSEs. Lipid pockets like these were
common in HSEs.
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Figure 5.15: Raman depth profile of a day 7 HSE while in culture. (a-c) Raman spectra
from the profile at different depths. Markers of collagen begin to appear at 60 µm
below the surface - Amide I widens, collagen peaks of Amide III become more intense
compared to 1400-1300 cm-1 and proline peaks increase relative to phenylalanine).
Epidermis thickness can be estimated to be at least 50 µm from this non invasive
profile.
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Figure 5.16: Raman depth profile of a day 14 HSE while in culture. (a-c) Raman
spectra from the profile at different depths. No markers for collagen are observed at
even 90 µm below the surface. The epidermis is estimated to be over 90 µm thick and
lipid markers indicate a thick lipid-by-layer has formed.
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Figure 5.17: (a) 2D depth slice of human skin tracking the change in the 1400-1200 cm-1
band of collagen (intensity of area below 1300-1200 cm-1 relative to 1400-1300 cm-1).
Using only this region, epidermis thickness is estimated to be approximately 60 µm.
(b) H&E stained section of the same sample after being processed. (c-d) Height profiles
corresponding to the dashed line extracted from the map grid. Collagen markers are
apparent between 60 and 120 µm below the surface with 785 nm excitation.
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et al. 2011b, Broding et al. 2011]. Pertinent too because many commercially available
HSEs are reported to have poor barrier properties, and that factors such as temper-
ature and humidity affect the quality and formation rate of SCs in culture [Hoath,
Tanaka, and Boyce 1993, Nolte et al. 1993]. For example, compared to native skin,
expression of some differentiation markers such as involucrin, and keratins 6, 10 and 16
have been shown to be different in HSEs. Involucrin was found in all suprabasal layers
instead of only in granular layers. Whereas keratin varied from its expression in all
suprabasal layers (previously associated with wound healing [Mansbridge and Knapp
1987]) to gradients along the thickness of the epidermal layer [Boelsma et al. 2000,
Banks-Schlegel and Green 1981]. It is suggested that these markers indicate an acti-
vated epidermal layer, and normalising its expression might improve barrier properties
of the SC [Thakoersing et al. 2011]. The percentage of each of the three lipid classes
of the SC, ceramides, cholesterol and free fatty acids, are also different in HSEs. The
percentage distribution of these lipid classes can be altered with additional ingredients
in the cell culture media to allow optimisation of barrier forming abilities. Vitamin C
for example has been shown to increase the amount of ceramides and form lamellar
structures more closer to native skins [Ponec et al. 1997]. Conditions that may improve
SC properties and tools that can measure them command attention.
There are several methods employed in the study of SC lipids. Many of which re-
quire isolation of the SC from intact skins for lipid composition and organisation (e.g.
High Performance Thin Layer Chromatography). Or immunohistological analysis for
studying differentiation markers. Here, using RS, spectral ranges between 3400-2800
and 1200-990 cm-1 were used to study the lipid content and phase. We were able to
establish the presence (or lack thereof) of a lipid-bi-layer on HSE surfaces both in vivo
and in vitro. And based on the conspicuous lipid peaks between 3400-2800 cm-1, that
lipid content between native and HSE tissues are different. This is despite the HSEs
being made from cells isolated from the same native skins. The region 1200-990 cm-1
revealed the surface of day 7 HSEs are dominated by gauche phase lipids compared to
mature day 14 HSEs which had a combination of both trans and gauche lipids. How-
ever, while the method is very descriptive for small collection volumes, measurements
made from a single location did not always hold true for the entire sample because
lipid packing within HSEs showed a lot of regional variation. For example, some day
14 HSEs had localised lipid pockets instead of a continuous lipid layer. Gauche lipids
are associated with increased permeability. HSEs in general are found to be more per-
meable, sometimes by a factor five [Thakoersing et al. 2011], compared to native skins.
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Ability to ascertain the presence and phase of the SC on these mixed surfaces or its
transition (from gauche in early-stage to trans/gauche) while in culture is an advantage.
In fact, it is suggested that correlation between the ratio I2880/I2840 and phase tran-
sition is comparable to differential scanning calorimetry (DSC) [Wegener et al. 1996].
DSC gives very detailed information on the phase transition temperature, its rate of
change and the magnitude of transition but requires SCs to be separated and/or use of
solvents to extract lipids for analysis. Results from extracted lipids do not always agree
with isolated thin SC layers [Silva et al. 2006]. Whilst RS data is not as detailed, the
measurements were taken in-line, from SC layers still in their natural state. And due to
high spatial resolution, lipid profiles across epidermal layers are measured. This does
not give an actual quantitative value for lipid content at each point, but allows relative
concentrations to be tracked against depth. Profiles from native skin samples with
confirmed, water-tight barriers can then be used as baselines from which the quality
HSEs may be assessed.
Proteins: In the high wavenumber region (3200-2600 cm-1), the proteins of the SC
and epidermis were found to be highly folded compared to the dermis. For intact skin,
the unfolding in the dermal layers seemed to correlate with the increase in hydration.
The less hydrated upper layers function as the primary barrier to the environment
which might explain the design of the highly folded protein structures. In such confor-
mations, the proteins can form little interaction with external compounds forming an
effective boundary. In the dermal layer the protein is freer to form bonds with other
molecules such as water. The bonding with water strengthens and stabilises the layer
due to the network of hydrogen bonds created.
The amide bands were found to have considerable differences between layers of the
skin (epidermis and dermis) and between intact and sectioned skin. Interpretation of
these changes is difficult due to mode mixing as many of the tissue constituents have
overlapping peaks and bands here. Amide I position suggests that proteins of the SC
and epidermis are predominantly in α-helix form, both in vivo and in vitro. But indi-
vidual proteins can rarely be identified against a background of other proteins. Instead,
the bands are used to ascertain information on the overall protein content. An excep-
tion is perhaps the dermis. Over 75% (wt) of the dermis is collagen. So changes in
the dermis spectra are tentatively assigned to collagen related effects. For example,
here, the shift observed for Amide I in sectioned tissue is thought to point to a large
portion of dermal proteins taking Unordered and β-sheet form. The big difference in
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the position between intact and sectioned dermis is a shift toward lower wavenumbers
suggesting that in vivo, a high percentage of dermal proteins are in unordered and
α-helix form. This is perhaps indicative of a dependency of hydration on collagen con-
formation because the effect is also observed in the spectra collected from hydrated
DED samples versus from dried DED samples. This is also observed in some Amide III
bands where the percentage distribution of α-helix, unordered and β-sheet peaks vary
between intact, wax embedded and frozen samples. Assuming hydration is the main
cause of this effect, a clue also comes from the Amide II band. This band is not seen
to shift to a statistically significant extent in sectioned tissues (position shift is close
to system resolution) compared to intact samples where the shift is 4 ±1 cm-1. Seen
altogether, in hydrated samples Amide I shifts to a lower wavenumber while Amide II
shifts to a higher wavenumber. Downshifts in Amide I position are reported in pro-
teins as they become more stable [Myshakina, Ahmed, and Asher 2008]. Backbone
stability would decrease the frequency of υ(C=O) vibrations (Amide I) but increase
the frequency of δ(C=O) vibrations (40% Amide II). More importantly, stiffness of the
backbone would increase the frequency of vibrations from side chains as their confor-
mational freedom is not restricted. Collagen is mainly made up a sequence of glycine,
proline and hydroxyproline. Glycine is a big part of the backbone accounting for every
third amino acid in the sequence. It is neutral compared to proline and hydroxyproline
which are hydrophilic. The structure of collagen is very sensitive to hydration because
it depends on water bridges formed between hydrophilic counterparts to the peptide
links [Bella, Brodsky, and Berman 1995]. Water molecules are trapped within the he-
lical lattice effectively holding the 3d structure by binding the triple helices. Based on
the spectral features just mentioned, an ad interim theory might be that: frequency
of collagen backbone stretching vibrations (υ(C=O)) decrease in water bound collagen
(stiffer structure) but the frequency of bending vibrations of the carbonyl oxygen atoms
(δ(C=O)) that are close to water molecules and the bending vibrations of the peptide-
peptide hydrogen bonds (δ(N-H)) increase (assuming these arise from side chains whose
conformational freedom is restricted due to water bonding). To note also is the increase
in proline and hydroxyproline peak intensities (920 and 855 cm-1) relative to phenylala-
nine in hydrated samples. This altogether makes sense as in hydrated samples, more
of these hydrophilic side groups are probably revealed.
Layer characterisation: Here, PCA showed that variations due to layer composition
is greater than both source and sampling variations. In both the 1760-1180 and 985-
600 cm-1 regions, the variations described by the PCs cluster each of the tissue layers
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(epidermis and dermis) separately. In the amide region, it was noticed that lipid and
nucleic acid residues contributed to a slight separation between the SC and epidermis.
Lipid content was found to vary within and between samples with separate analyses.
The PCA for 985-600 cm-1 was set up because of this as the region has little contribution
from lipids. As such, the clustering in the scores plot is almost entirely due to differences
in nucleic and amino acid vibrations in the layers. Very little work is done on this region
making it difficult to attribute this separation to any particular NA or AA. However,
that SC spectra can be dissociated from epidermis spectra suggests the composition of
NAs and AAs in SC maybe used to detect SCs layers even in the absence of mature
lipids.
In vivo profiling: This work has presented some structural information of proteins
and lipids extracted only from Raman data. The information is not as detailed as
those that maybe obtained through techniques that are established in the study of
these biological materials. A big drawback is that for much of these materials, Raman
data has not been correlated with particular states, it still requires complementary
tests to be carried out in order to be more descriptive for studying individual species
such as proteins or lipids. An advantage lies in its ability to provide little information
on all of these species by itself without dyes and in their natural state. This makes it
a great tool to adapt for monitoring tissues for general quality purposes. Here, using
2D cross-sectional Raman maps with 785 nm excitation and single point depth profiles
using 633 nm excitation, the boundaries of the epidermal layer were identified under
both sterile conditions and reasonable time-frames. This might prove invaluable in
monitoring the maturation of HSEs in culture and in assessing how culture conditions
affect the formation of each layer. In applied research, ability to measure the thickness
of the epidermal layer would be useful for any topical application that must diffuse into
the dermal layer. Such as tracking the absorption of trans-dermal pain creams. Or
fewer samples would need to be sacrificed for time-resolved studies of factors affecting
growth patterns. In clinic, estimating the thickness of epidermal layer would be useful
in so far as a particular thickness can be linked to successful graft adherence. For
example, the point at which a graft has a significantly better percent chance of taking
when grafted onto patients. Whereas in manufacturing (large-scale HSE production),
product consistency is dependent on the ability to control reactor environments to suit
the conditions optimal for each new batch. Particularly because cell behaviour can
be different even under identical process conditions. Batch turnaround times can be
improved upon with measures from which rates of skin maturation can be obtained.
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As well as the product, there are several examples where RS has been used to measure
various rate limiting factors in bioreactors. For example, it has been used successfully
for in-line monitoring of mammalian cell culture bioreactors over long reactor runs
[Moretto et al. 2011, Li et al. 2010] and over different sized calibration sets [Abu-Absi
et al. 2011]. In most cases, predicted glucose, lactate, glutamine, glutamate, ammonium
and viable cell densities compared well to ex-situ measurements. Despite the potential,
several obstacles remain for any of these advancements to be made. Sample-to-sample
variation remains large. Dermal components are identified with ease in all samples but
profiles from each sample required different types of processing: there was no standard
setting that worked for all samples. The spectral features are also only shown to work
for normal skin samples (native or HSE). Namely, markers for collagen and relative
lipid-protein concentrations. Many disease states of the skin cause changes to these
structures.
5.4 Conclusions
Several spectral features that provide some indication as to the quality of HSEs in
vitro and in culture are explored in this chapter. Spectral differences arising from
compositional and structural differences between skin layers are found to be sufficiently
large to outweigh sampling variations (between HSEs, or HSEs and native skins) in
normal skins. Layers are identified, barrier properties are assessed and some effects of
hydration are observed on dermis structure. Prospects for monitoring (these features)
maturation of HSEs in culture are good, but reproducibility of in vivo profiles were
lower compared to those obtained from tissue sections. These were only successful 50-
60% of the time. However, the quality of spectra obtained from the successful profiles
were almost comparable to in vitro data.
Chapter 6
Melanoma
6.1 Introduction
Features used to diagnose and study melanoma varies greatly in scale from tissue level
properties down to DNA level (Chapter 1). Type and drawbacks also vary. For exam-
ple, sensitivity and specificity of histopathological features can change depending on
several factors such as subtype and lesion size [Urso et al. 2008]. Overall, using a com-
bination of features is typically very accurate in identifying subtype and in prognosis.
But it is also subjective. In any given sample set, there may be no unanimous agree-
ment by pathologists on up to 40% of melanoma samples [Farmer, Gonin, and Hanna
1996]. Melanoma markers are as variable. Some are more accurate in certain subtypes
or locations (e.g. Melan-A is not as sensitive to non-cutaneous melanoma). Many of
them are used in conjunction with histopathological features as very few markers have
prognostic significance independent of factors such as thickness (e.g. p16, MMP-2).
Markers are particularly useful in evaluating patients that need aggressive treatment
who otherwise might be considered low-risk based on histopathological features alone
[Larson, Konat, and Alani 2009]. For example, 5-year survival can decrease signifi-
cantly for patients who are MMP-2 positive (<34%) versus negative (>34%) [Va¨isa¨nen
et al. 1998]. Increasingly, a number of oncogenes are being studied to refine classifica-
tion and for their prognostic value. The activation of mutations cause disruptions to
downstream proteins (e.g. uncontrolled receptor tyrosine kinase activity with BRAF
mutations) which also make them suitable for targeted therapeutics.
Promising treatment options are emerging with the increase in trials for targeted ther-
apies (e.g. BRAF inhibitors) and immunotherapies. Still, there is much to learn about
89
CHAPTER 6. MELANOMA 90
the mechanism of progression. For example, the prevalence of BRAF mutations in
melanoma lead to trials with BRAF inhibitor drugs that in some cases have been
very successful. And yet, as many benign nevi (80%) have BRAF mutations [Uribe,
Wistuba, and Gonza´lez 2003]. Transformation into malignant state involves multiple
(likely concurrent) steps including strong non-genetic components [Huang, Ernberg,
and Kauffman 2009]. It is suggested that changes to the microenvironment may direct
initial transformation as well as promote progression and invasion following transforma-
tion [Bissell and Radisky 2001, Tlsty and Coussens 2006]. Compositional and structural
information from RS data may provide some information on aspects of tissue change
during these stages that may compliment other data used in melanoma research. This
chapter outlines some preliminary observations made on the differences between tissue
engineered normal skins and tissue engineered melanoma models made with A375SM
and C8161 melanoma cell lines.
6.2 Results
6.2.1 A375SM type melanoma composites
Sample features of A375SM models were divided into three categories based on the
commonest morphological feature, Figure 6.1. These were: (1) areas with clusters of
assumed A375SM cells encapsulated within epidermis, (2) areas with assumed A375SM
cells spread over the composite surface and (3) areas bearing close resemblance to
normal skin. A375SM cells have been reported to present as balls of cells within the
epidermis of TE models previously [Eves et al. 2003].
6.2.1.1 Regional variations in Category 1 areas using PCA
Five large areas from three A375SM samples were picked to study compositional dif-
ferences in clustering regions. The areas were around 200-300 µm2 in size. Each area
included a tumour cluster with defined borders that could be separated from surround-
ing tissue. Every spectra from these areas were location-labelled and then colour coded
for: (i) tumour cluster, (ii) epithelial tissue surrounding the cluster and (iii) dermis.
PCAs for two of these areas are presented in Figures 6.2, 6.3 (see Appendix for others).
For each case, the scores plots contain a PC that separates dermis from superficial
layers and a PC that separates tumour clusters from surrounding tissue.
PCs that separate dermis from superficial layers include features related to collagen
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Figure 6.1: H&E of A375SM melanoma models showing three morphological categories:
(a) normal HSE, (b-d) A375SM cells in clusters within the epidermis, (e) A375SM cells
spread over the surface of the composite, and (f) areas that look almost like normal
tissue engineered skin.
CHAPTER 6. MELANOMA 92
(1300-1140 cm-1 and 920, 855 cm-1), nucleic acid (NA) residues (1400-1300 cm-1) and
lipids (1140-1060 cm-1), Figure 6.2c, 6.3c. Many of these bands have already been dis-
cussed in Chapter 5 and bear close resemblance to features that separate these layers in
normal skin (Chapter 5, Figure 5.1). Loading plots for PCs separating tumour clusters
from surrounding tissue describe variations relating to differences in Amides and lipid
phases as well as some significant contributions from glycogen and amino acid (AA)
residues. Some of these features are highlighted below.
Differences in protein structure within A375SM clusters: Position of Amide I
maxima in normal skin SC and epidermises described predominantly α-helical proteins
in these layers and β-sheet proteins in the dermal layer (Chapter 5). For A375SM mod-
els, dermis spectra still suggests β-sheet proteins and epithelial layers both surrounding
tumour clusters and further away both describe a high percentage of α-helical proteins.
A difference is observed in spectra collected from within tumour clusters: Amide I
maxima here is suggestive of more unordered and β-sheet conformations instead of α-
helix (Figures 6.4a, 6.4b). This is seen consistently in all clear/defined tumour clusters
within the viable epidermis, indicating minor conformational alterations in the proteins
of these A375SM cell clusters.
Higher percentage of gauche lipids in A375SM models: In normal skin, near
equal contribution of both trans and gauche lipids were observed in the viable epidermis
of most HSEs (Chapter 5). In contrast to this, contribution from gauche lipids are
higher in A375SM clusters, high density A375SM cells spread over the surface (category
2 areas) and in epithelial tissue further away from the clusters (category 3 areas). The
biggest difference is observed at the surface where trans-to-gauche ratio is much lower
compared to normal skin SC, Figures 6.4c, 6.4d, Table 6.4.
Increased glycogen presence in tissue surrounding A375SM clusters: A no-
table difference between the epidermis surrounding A375SM clusters in these models
and normal skin epidermis is a peak at 481 cm-1, Figure 6.5. This peak represents
skeletal deformation of glycogen [Konorov et al. 2011]. It is found in areas around clus-
ters but not in normal looking epidermis spectra far away from clusters or epidermis
spectra in areas with A375SM cells spread over the surface. This suggests localised
glycogen accumulations in epidermal cells in the vicinity of tumour clusters possibly
in response to a foreign body within the area (whole epidermis is not activated). The
storage response appears to be active at least to a range of 100 µm from clusters.
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Differences in AA residues: Peaks attributed to Tryptophan (Trp), Phenylala-
nine (Phe) and Tyrosine (Tyr) show apparent sensitivity toward separating tumour
areas from surrounding tissue. The differences are summarised in Table 6.1. The ratio
I1360/I1340 from the Fermi doublet of Trp is considered a marker for its configuration
within proteins [Harada, Miura, and Takeuchi 1986, Takeuchi 2003]. It details whether
the Trp chains are exposed (I1340 >>I1360) or folded within the protein (I1340 >I1360).
In normal skin, the ratio is lower in SC compared to epidermis. This reflects hydropho-
bicity in the SC: Trp chains aren’t accessible to water molecules as they are folded
within the protein. Tumour clusters exhibit this same configuration even when the
cluster is within the viable epidermis. Another Fermi doublet is seen at 850 and 830
cm-1 that arises from vibrations of the phenolic ring of Tyr [Siamwiza et al. 1975, Barry,
Edwards, and Williams 1992]. Tyr chains are exposed and free to form intra-molecular
bonds when the ratio I850/I830 is approximately 10:8. Changes to this ratio reflects
changes to the ionization state of this AA. Relative intensity of 830 cm-1 increases
within most cluster areas describing buried Tyr chains. The two AAs together possibly
suggest hydrophobic behaviour in clusters of A375SM cells.
Table 6.1: Amino acid peaks of significance in A375SM category 1 areas based on PCA
Peak
(cm-1)
Assignment Observed effect
1604 δ(C=C) of Phe, Tyr [Notingher et al.
2002]
Higher inside clusters compared to
surrounding tissue.
1360 Ring breathing mode of Trp [Miura,
Takeuchi, and Harada 1989]
Higher inside clusters.
1340 Ring breathing mode of Trp [Miura,
Takeuchi, and Harada 1989]
Higher in cluster surrounding tissue.
1210 υ(C-C6H5) Tyr, Phe, Trp [Nijssen et
al. 2002]
Higher inside clusters.
850 Ring breathing mode of Tyr [Not-
ingher et al. 2002]
Higher in cluster surrounding tissue.
830 Ring breathing mode of Tyr [Not-
ingher], υ(O-P-O) [Nijssen et al. 2002]
Higher inside cluster.
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Figure 6.2: PCA results of A375SM category (1) areas I: (a) White light and H&E
images of PCA area. Dashed circle in H&E image represents A375SM cell cluster.
Data points in white light image are colour-coded based on H&E features. (b) Scores
plot for the model setup over the region 1800-450 cm-1. The plot has a PC separating
dermis spectra (PC2) and a PC that separates inner tumour clusters from surrounding
tissue (PC4). (c) Loading plots of PCs from (b). PC loadings that separate tumour
from surrounding tissue highlight areas associated with various AAs, lipid phases and
Amides.
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Figure 6.3: PCA results of A375SM category (1) areas II: (a) White light and H&E
images of PCA area. Dashed circle in H&E image represents A375SM cell cluster. Data
points in white light image are colour-coded based on H&E features. (b) Scores plot
for models setup over the region 1800-450 cm-1. The plot has a PC separating dermis
spectra (PC2) and a PC that separates inner tumour clusters from surrounding tissue
(PC3). (c) Loading plots of PCs from (b). PC loadings that separate dermal layers are
nearly identical in all category (1) area PCAs. PC loadings that separate tumour from
surrounding tissue pick out most of the same features as seen in Figure 6.2.
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Figure 6.4: Features of A375SM (right) category 1 areas compared to normal HSEs
(left): (a,b) 1st derivative spectra of Amide I band. Percent contribution of α-helix,
Unordered and β-sheet proteins in melanoma-dense clusters and surrounding epithelial
tissue are different. (c,d) 1st derivative spectra of high wavenumber area (3200-2600
cm-1). I2840/I2880 ratio suggest a more fluid (gauche) lipid compositioin in A375SM
models. Spectra from each colour-code has been averaged over several sample areas.
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Figure 6.5: Features of A375SM category 1 areas (b) compared to normal HSEs (a):
Raman pectra of spectral range 700-450 cm-1 showing the increase in the glycogen
peak at 481 cm-1 relative to the υ(C-S) peaks at 640 and 620 cm-1. Spectra from each
colour-code has been averaged over several sample areas.
6.2.2 C8161 type melanoma composites
Morphological features of C8161 models were found to be more heterogeneous compared
to A375SM models. Sample features were divided into four categories to describe
different behaviours, Figure 6.6. These were: (1) areas with high densities of C8161
cells spread across the surface, (2) areas where large numbers of C8161 cells had invaded
the dermis in close proximity to the basement membrane, (3) areas with clusters of
assumed C8161 cells encapsulated within the epidermis and (4) areas with no apparent
C8161 cells. Areas of category (1) were nearly always accompanied by large swirls
where the epidermis was apparently degrading. This cell line is known to disorganise
the epidermis and were seen to aggressively invade the dermis when cultured with
keratinocytes and fibroblasts [Eves et al. 2003].
6.2.2.1 Spectral features of Category 1 and 3 areas
PCA loadings (Appendix) indicated AA bands for Tyr and Phe were significantly dif-
ferent in areas dense in C8161 cells versus surrounding tissue. In particular, a peak at
1583 cm-1 that represents δ(C=C) vibrations of Phe [Talari et al. 2015] shows apparent
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(a) (b)
(c) (d)
(e) (f)
Figure 6.6: H&E of C8161 melanoma models showing four morphological categories:
(a) normal HSE, (b-d) Areas with C8161-dense surface layers and areas with clusters
of C8161 cells within the epidermis. (e) Areas with C8161 cells invading into dermis.
(f) Normal looking areas of C8161 models.
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sensitivity to separating the surface C8161 layer from to the rest of the sample areas.
Another notable feature that repeated in most of the PCAs was at approximately 781
cm-1. This peak consistently separated the surface layer (where it was the highest) and
the epidermal swirls (where it was the lowest) from other surrounding tissues. The peak
represents Uracil based ring breathing modes of DNA and RNA [Talari et al. 2015].
It likely points to high cell densities in the surface layer. A number of other spectral
changes identified in these areas were similar to those found in A375SM models, Figure
6.8. In Amide I, C8161 clusters again describe a greater number of Unordered proteins.
Overall, Unordered and β-sheet proteins appear to be higher compared to normal HSEs
even in epithelial tissues further away from C8161 dense areas. Lipid phase of these
melanoma-dense areas also appear more fluid and epithelial tissue surrounding clusters
show increased glycogen storage. In C8161 models these effects are seen in much larger
areas (spread across whole samples) compared to A375SM models (closer to seeding
points) but don’t appear as distinct from normal skin spectra as A375SM models. This
is evidenced especially in the 985-700 cm-1 region, Figure 6.9.
The spectral features mentioned in this section are ones that held true for most of
the areas in the samples studied. However, it needs to be emphasized that spatial
consistency of the epithelial layer between samples was much lower than in A375SM
models. A final interesting feature of the surface-spread C8161 layer is a change in the
sulphide peaks at 640 and 620 cm-1. There is a major difference in the ratio of these
peaks for approximately 75% of the surface-spread spectra, 620 >640 cm-1 (Figure
6.8d). This is not seen in any of the other TE skin models made.
6.2.3 Comparison between features of A375SM and C8161 melanoma
models
The two melanoma cell lines used in this work to some extent represent two differ-
ent stages of melanoma that may be found in situ. In tissue engineered skin models
A375SM cells form clusters and grow larger over time within the epithelial layer with
occasional invasion into the dermis: assumed stage II. In constrast C8161 cells are
highly invasive and appear to quickly spread across large surface areas and invade into
the dermis: assumed stage III or IV (see Appendix for melanoma staging &grading sys-
tem). Samples were difficult to identify when intact: models constructed with both of
these cell lines formed amelanotic samples and C8161 cells have previously been shown
to not stain for the two common melanoma antibodies (HMB-45, S100) [Eves 2001]. It
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(a) (b)
(c) (d)
Figure 6.7: H&E and white light images of two C8161 model areas from categories 1
and 3 used as part of PCAs. Collection points are seen as red dots. Each point was
compared to adjacent H&E stained sections to assign area type. See Appendix for PCA
results.
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Figure 6.8: Features of C8161 category 1 and 3 areas: (a) 1st derivative spectra of
Amide I. There is increased percentage of Unordered and β-sheet proteins compared
to normal HSEs. Even the surrounding tissue is much higher in Unordered proteins.
(b) 1st derivative spectra of the high wavenumber region (3200-2600 cm-1). As with
A375SM models, lipid packing appears to be more fluid in C8161 models compared to
normal HSEs. (c) Raman spectra of spectral range 700-450 cm-1 showing an increase
in Glycogen peak at 481 cm-1 relative to υ(C-S) peaks. (d) Difference in the ratio of
υ(C-S) vibrations at 640 and 620 cm-1 in some surface spread C8161 dense layers.
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is of interest to find spectral differences between melanoma models and normal HSEs
but also between the two melanoma types because of this vastly different behaviour.
Significant band ratios between A375SM, C8161 and Normal skin models:
Several spectral differences between the models are highlighted in Table 6.4. A number
of these are protein-specific: (1) There appears to be minor differences in the 2930 cm-1
protein band in cancerous tissues. The position of this band was previously attributed
to a compact and highly folded protein nature in normal skin SC and epidermis (Chap-
ter 5). The shifts here are small but consistent in all cancer samples and might suggest
some disorganisation in protein architecture of whole melanoma composites. (2) Within
tumour clusters of both cell types, and surface-spread tumour layers, Amide I position
strongly suggests higher percentage of unordered and β-sheet conformation proteins
instead of α-helix: Unordered >β-sheet in clusters but β-sheet >Unordered in surface-
spread layers. As it is observed in models with both cell lines, it is possible that the
differences in these ratios arise from: (i) requirements of a clustering mechanism versus
for proliferation without any boundaries or (ii) an indication of the proliferative state
of the melanoma cells. (3) The ratio I1340/1360 represents the ratio of surface exposed
versus buried Trp moieties within epidermal proteins. In cancer models, there is an
increase in the number of buried Trp chains. This likely indicates a more hydrophobic
environment but also a change in Trp-mediated processes compared to normal skin.
(4) Apart from structural differences, protein-to-lipid ratios within the models also
show some variation. The ratio I2930/I2840 was previously used to trace lipid-dominant
epidermal layer down to protein-dominant dermal layer (Chapter 5). The relative con-
centration of proteins and lipids appear to be similar between melanoma models and
the superficial layers of normal skin. The biggest difference is seen in the surface-spread
tumour layer of A375SM models where protein content is markedly decreased and fur-
thermore, whilst the overall lipid content is perhaps the same, the packing order of
lipids is not. Compared to normal skin, cancer models show a higher percentage of
gauche lipids in areas of every tumour-invaded category.
Both cancer models also showed increased glycogen storage in epithelial tissues sur-
rounding tumour clusters compared to normal skin. The increase was much more
prominent in A375SM clusters. Tyr configuration also appears to be different in
melanoma-dense clusters, Figure 6.9, Table 6.2. A big difference between A375SM
and C8161 models is also at 780 cm-1. This band represents ring breathing vibrations
of DNA and RNA bases. It is considerably lower in A375SM models compared to both
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C861 and normal skin models.
Classification based on epithelial layer spectra: A LDA model was setup with
data from entire epithelial layers of A375SM, C8161 and normal skin models in order
to determine if the tissue state could be predicted from Raman spectra despite large
biochemical variations within cancer samples, Table 6.3. LDA was setup with three
class categories: normal (50), A375SM (80) and C8161 (80). Five random spectra from
each class category were left out at each run until a total of 20 spectra (so called non
labelled samples) were tested. Specificity was found to be very high and sensitivity
to the cancer state was also very high (no melanoma samples have been assigned to
Normal class). However, sensitivity to detecting models of the specific melanoma cell
lines was much lower.
Table 6.2: Comparison between melanoma and normal HSEs in the spectral range
985-700 cm-1
Tissue 780 cm-1 I750/I760 I850/I830
Normal High in epidermis, low
in SC
High in SC, decreases
in epidermis
I850 higher in SC and
epidermis
A375SM Very low in all
A375SM areas
I750 much lower, I760
higher compared to
normal areas
I830 much higher in
clusters, similar to
normal in surrounds
C8161 High in all areas ex-
cept clusters
I760 higher, I750 similar
to SC in all areas
I830 higher in clusters,
similar to normal in
surrounds and surface
Table 6.3: Classification results for normal skin and melanoma models. The model was
setup over the range 3400-500 cm-1 and from spectra collected from all epidermal areas
of the melanoma models (clusters, surface spread and epithelial tissue far away from
any tumour cluster). Normal state can be identified accurately but the parameters
used in this LDA model do not accurately predict models of the different melanoma
cell lines.
Predicted Normal A375SM C8161
Actual
Normal 19 0 0
A375SM 0 7 2
C8161 1 13 18
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6.3 Discussion
Raman analysis on tissue engineered melanoma composites built with two melanoma
cell lines are presented in this chapter. In studying normal skin layers, spectral features
relating to each layer were first assigned via visual observations of location-labelled spec-
tra. Subsequent analysis with MVA methods verified that these features held true for all
samples. This approach was taken because normal skin layer composition was assumed
already to be quite homogeneous within samples (epidermis, dermis) and the layers
were easily identified with H&E staining. Melanoma samples by comparison showed a
lot of morphological variation within and between samples. The type of variations were
mostly consistent. Sample areas were first divided up into categories representing the
commonest morphological features. The approach was then to perform PCA over whole
areas and focus on loading features that held true in all areas of a respective category.
This worked better in A375SM models. Trends in several spectral bands were observed
repeatedly in the loadings separating melanoma-dense areas from surrounding tissues.
Here we discuss ones related to glycogen accumulation, lipid disordering and changes
to protein configurations. These are unlikely to be characteristic of only melanoma.
Many of the spectral changes identified here are also seen in other disease states (e.g.
immune disorders such as psoriasis) and in tissues put under stress (e.g. tape stripping,
hypoxia). Conjectures about their role in melanoma here are perhaps better considered
as stepping stones toward tailoring experiments more appropriate to further define the
causes and consequences of the spectral differences.
Glycogen accumulation in tissue surrounding tumour clusters in epidermis:
In this study we reported localised glycogen accumulation in the primary surrounds of
tumour clusters located within the epidermis. The effect is found to be specific to areas
only in the primary vicinity of clusters, not the entire epithelial layer. It is unlikely
that the effect arose from culture conditions: Glycogen storage is a stress response.
Exposure to UV radiation [Lobitz et al. 1962] or conditions such as psoriasis [Harmon
and Phizackerley 1984] cause increased glycogen storage across entire skin areas affected
by these conditions. Localisation in these cancer models suggests the stress response
more likely arose from changes to microenvironment. It is unclear whether or not
the activation is due to a foreign body (melanoma-spheroid) or if the keratinocytes
are responding to broader bio-signal specific consequences of the melanoma clusters.
Melanoma cells migrate to the SC and spread across surface even though they are added
on the same day as keratinocytes. In A375SM models, it was previously reported
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Figure 6.9: Comparison between melanoma and normal HSEs in the spectral range
985-700 cm-1. Highlighting differences in Tyr, Trp and a peak at 780 cm-1 in in the
2nd derivative spectra for (a) Normal, (b) A375SM, and (c) C8161 models. Overall,
tumour surrounds in C8161 models resemble normal HSE more closely than A375SM
models.
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that melanoma clusters -chew- through the epidermal layer [Eves et al. 2003]. The
chewing action may activate mechanisms associated with wound healing which is also
known to increase glycogen storage in keratinocytes. In wound healing, a gradient of
increasing accummulation is observed from the marginal epidermis (x3 normal) to the
migrating epithelium (x7-13 normal) [Hoopes and Im 1974]. Stress response is also
biphasic. Highest glycogen content is seen approximately 24-48 hours after the stress is
induced in the microenvironment and returns to normal 24-48 hours after it is removed
[Straseski et al. 2009]. While unlikely to be melanoma-specific, the effect is interesting.
And though it was not quantified here, the peak at 481 cm-1 has been shown to be
a good indicator of glyogen content in tissues on par with Periodic acid Schiff (PAS)
staining. Careful calibration of the peak has been shown to quantify glycogen content
even in cell cultures [Konorov et al. 2011].
Protein configuration different in tumourous areas: The high wavenumber pro-
tein band and Amide I suggest the ratio of α-helix, Unordered and β-sheet proteins are
different between cancer models and normal skin. The contrast between the Amide I
bands is quite plain but reasons for the change are unclear. Based on this band alone,
the conformations of proteins were strictly maintained in normal HSEs (very minor
changes to ratio throughout epithelial layers in all samples) whereas it appears that
melanoma cells comprehensively cause alterations in protein structures in the system.
The ratio is even different between melanoma clusters and surface-spread melanoma
layers. This suggests there isn’t a single melanoma-specific state of protein expression
but that it is dynamic. Expression likely changes depending on the microenvironment
and/or the stage. Peaks related to certain AAs also point to structural modifications
in proteins.
In these cancer models, three AAs in particular were of interest: Phenylalanine (es-
sential), Tryptophan (essential) and Tyrosine (conditionally non-essential). These AAs
belong to a family of proteinogenic AAs. Proteins they build play a critical role in reg-
ulating homeostasis via their catabolic products and through their function in key sites
for enzyme activation. Quantification of these AAs are difficult due to mode mixing.
We report instead that the configuration of Trp and Tyr are different in the cancer
models. This likely suggests some changes to the activity of Trp and Tyr mediated
products. The exact changes cannot be elucidated based solely on data from these
samples but examples of how even minor changes in Trp and Tyr can affect tissues are
highlighted below.
CHAPTER 6. MELANOMA 108
Trytophan: I1340/I1360 ratios here indicate a higher percentage of proteins with buried
Trp chains in cancer samples compared to normal HSEs. Trp is mostly used up through
the Kynurenine pathway and its catabolism products are immunoregulatory. Changes
to the rate of its breakdown is implicated in several diseases including HIV and neu-
rodegenerative disorders [Schro¨cksnadel et al. 2006, Ruddick et al. 2006, Campesan
et al. 2011] because the catabolism products are thought to facilitate immune tolerance
[Moffett and Namboodiri 2003]. The rate limiting step of the breakdown is via the
enzymes tryptophan-dioxygenase (TDO) or indolamine-dioxygenase (IDO). TDO and
IDO activity is dependent on the hydrophobic pocket formed when the Trp chain is
buried within the protein [Thackray, Mowat, and Chapman 2008]. Reducing the hy-
drophobic nature (thus changing the shape of the activation pocket) has been shown
to affect substrate binding [Chauhan et al. 2012]. In all areas of the cancer samples,
I1340/I1360 ratios suggests hydrophobic pockets exist in a greater number of proteins
compared to normal skin. Assuming this means more active TDOs, it could mean
increased Trp catabolism in cancer samples. Another theory is that the buried state
of Trp chains may be markers for proliferative state. This theory is mostly realised
in fluorescence spectroscopy studies. Trp fluorescence increases as Trp moieties are
folded into proteins versus when exposed. Using this method, the amount of buried
chains are found to increase in skin with UV exposure and after tape stripping of the
SC [Brancaleon, Lin, and Kollias 1999] and in the non-involved skin parts of psoriasis
patients [Gillies et al. 2000]. These groups report increase in fluorescence correlates
with proliferative activity. Based on this theory, proliferation in all areas of A375SM
models is greater than in normal skin epidermis. In C8161 models, whilst the epidermis
and C8161 cell clusters show very high proliferation, the rate appears to be lower in
surface-spread C8161 cells but these initial findings have limited use. 1360 and 1340
cm-1 peaks represent the aromatic ring breathing vibrations of Trp where changes to
ring orientation within the protein is reflected in the raman spectrum (1360 vs 1340).
However, the first step of Trp degradation directly involves the indole ring, Figure 6.10.
Vibrations associated with this ring at 1550, 1490 and 1430 cm-1 [Miura, Takeuchi, and
Harada 1989] are likely to be more informative because this pathway regulates systemic
Trp levels. The problem is that, here, these peaks are either very weak (1550 cm-1) or
are overpowered by other stronger bands (Amide II in 1490, 1430 cm-1). Trp-specific
trends in tissues may be better studied with UV Resonance Raman as Trp peaks are
enhanced by several orders of magnitude using this method [Caswell and Spiro 1986,
Sweeney and Asher 1990].
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Figure 6.10: First step of the Kynurenine pathway: Trp (left) from IDO is degraded
via the indole ring.
Tyrosine: Although I850/I830 ratios were not quantified, visual observations and PCA
suggest a greater number of buried Tyr chains in the clusters and surface-spread
melanoma cells. Tyrosine presents in a large number of proteins involved with signal
transduction, such as tyrosine kinases (PTK). Protein kinases are a group of catalytic
enzymes that are activated via the phosphorylation reaction with AA residues Ser-
ine, Threonine and Tyrosine. They regulate a number of vital metabolic and secretary
processes. Kinases share a common fold but differ in terms of the charge and hydropho-
bicity of AA residues. The shape and form of the hydrophobic pockets arising from
these differences influence substrate specificity [Ubersax and Ferrell Jr 2007]. In the
case of PTK, a single Tyr chain is phosphorylated for activation. After this, interaction
of the Tyr residue with a neighbouring Arginine residue activates PTK by opening up
and stabilising a hydrophobic, substrate-binding site [Nagar 2007]. PTK activation in
normal cells are very strictly regulated and balanced (on a need basis). Any disrup-
tions to the balance leads to cell transformations and causes unregulated cell growth
[Hunter 1998]. Drugs such as Imatinib inhibit this enzyme by binding to the active site,
preventing other substrates from binding it. This is an effective treatment in some can-
cers such as Chronic Myelogenous Leukemia (CML) where PTKs are permantly turned
-on- [Nagar 2007]. Changes to the I850/I830 ratio compared to normal skin is impor-
tant because it implies some changes to the location/orientation of Tyr chains within
proteins. Markers of Tyr hydrophobicity in particular are interesting because the level
of hydrophobicity has been shown to play a critical role in PTK function: Replacing
CHAPTER 6. MELANOMA 110
a buried Tyr chain with polar residues that reduce hydrophobicity also decreases sub-
strate binding [Tadaki and Niyogi 1993]. Interestingly, changes to Trp configuration is
seen in the entire cancer samples whereas changes to Tyr configurations are seen nearly
exclusively only in melanoma-dense clusters and layers.
Classification: LDA was setup over the full spectral range (3200-400 cm-1) and with
spectra from all areas of epidermal layers (clusters, surface spread, tumour surrounds).
Model accuracy may improve considerably if setup in narrower spectral ranges more
sensitive to differences between the two melanoma cell lines. Such as the amide bands,
and 985-700 cm-1 region. Here, classification was performed on data collected from
in vitro sections only. However, in vivo data collections were shown to be viable in
Chapter 5. This might lend itself to clinical applications. Collecting data from the
surface of melanoma models while in culture may be comparable to collecting data
from patients in the clinic. Clinical features of melanoma vary greatly depending on
subtype and stage. Many benign naevi also exhibit the same symptoms. Changes in
the size, shape and colour of a lesion are the main discriminators. The first step of
diagnosis is a physical examination. If the doctor considers the lesion suspicious, a
biopsy is taken for histological analysis:
• In the first step, the lesion is assessed based on either or both of the ABCDE
rule and the Seven-point checklist. Depending on experience, clinicians can be
very accurate in detecting melanoma. Sensitivity and specificity is reported to
be 90+%, 70+% for dermatologists with 10+ years experience but much lower
for 3-5 years of experience at 62%, 46% and even lower for non-dermatologists
[Cassileth et al. 1986, Chen et al. 2001]. This experience-dependence is the main
problem in this screening step.
• Histopathological analysis of melanoma includes examination of a large number
of morphological features. The sensitivity and specificity varies depending on
the feature examined. For example, it is 95.8%, 64.4% for Asymmetry, 63.9%,
75.3% for Irregular and confluent nests [Urso et al. 2008]. The method has very
high overall accuracy because a combination of features are reported (10+). This
diagnosis step is costly and invasive but is allows the staging and grading of
melanoma, critical in deciding on treatment course and prognosis.
It is tempting to consider the advantages of RMS for the second step. RMS does
not require any stains, has high sensitivity to biochemical composition and has high
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resolution. However, it is unlikely that there will be a single raman marker that com-
pletely separates melanoma tissues from normal skins due to the dynamic nature of
the disease (e.g. receptor expression is different in primary tumours and where it is
spread). Indeed, in this work, we have even seen differences in the melanoma-dense
areas of clusters and surface-spread layers. What LDA of raman data reports here
is a deviation from the normal state of skin tissue. This can lend itself to screening
melanoma if classification accuracies found with the in vitro sections can be extended
to spectra collected in vivo. Screening tools need to be objective, simple, non-invasive,
reproducible and accurate. RMS may fill all these criteria only if specificity remains
high when a larger number of skin conditions are added to classification models. With
a critical emphasis on benign conditions that can resemble melanoma.
6.4 Conclusions
In this chapter preliminary data regarding the regional effects of melanoma on skin
tissues and the results of predictive tissue classification in identifying melanoma tissues
is presented. The same properties that make RMS an effective tool in HSE quality
analysis also recommend it for cancer research: its ability to -see- many different bio-
chemical aspects of the tissue. Because whilst genetics can clearly help in searching
for the underlying cause and in treatment (BRAF inhibitor drugs in melanomas with
BRAF mutations), larger-scale properties of melanoma tissues may be more efficient
in understanding its routes of progression. We show here for example, that in TE
melanoma models, melanoma cells induce changes in the surrounding tissue that are
also common to other diseases. This opens up the possibility of looking into concepts
on the management of these other diseases; controlling progression via control of the
microenvironment. In a field governed with reductionism, tools that can quantify the
whole system with larger-scale properties like this should be explored and encouraged.
Chapter 7
Conclusions and Future work
This study has demonstrated the applicability of RS data to evaluate the quality of
tissue engineered skin models while still in culture. Where quality has been assessed in
relation to epidermal thickness and barrier properties. Estimation of these properties
have produced good results with no adverse effect to the culture conditions or tissue.
For depth profiling work, there is much interest in current literature in tracking topi-
cally applied products on skin tissues. The purpose of such work is tracing penetration
of the much stronger signals of drug formulations against the much weaker and often
overlooked tissue signals. Here, we tried to obtain depth profiles with skin spectra that
contains sufficient detail and resolution for qualitative information to be extracted.
The next stage of this work would likely be to compare and optimise the methods for
assessment of these properties with fiber optic probes for remote sampling. This would
favour both pharmaceutical testing of tissues and be of clinical interest as it may be
suitable for monitoring tissue transplants post implantation.
Where the option of remote access makes RS attractive for normal skin monitoring, its
ability to extract information from tissue sections independent from any stains and dyes
make it attractive for melanoma research. A big disadvantage is the lack of reference
data. Raman spectra are information rich but interpretation requires references. For
example, we are able to infer the position of Trp in proteins from the aromatic ring
peaks because these peaks have already been studied under conditions that expose and
bury chains in a number of protein derivatives. The same is not true for the indole ring
of Trp which hinders our interpretation of Trp breakdown.
Most of the RS work on melanoma in literature is done on biopsies. A large per-
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centage of these compare averaged spectra and then perform LDA on a set of biopsies
usually including some other types of skin cancers and a benign condition. Their con-
text is nearly always to show the accuracy RS data for screening. The applications
make use of predictive chemometric methods to determine the state of interest but
offer little attention to the nature/reason of changes. Biopsies are hard to come by
and scientists are typically reliant on whatever biopsies are made available to them
by the hospitals. This is in big contrast to having samples from carefully controlled
experiments to answer very specific questions. Proof-of-concept studies for screening
serve as good options in light of limitations related to sample access. Tissue engineered
models can be a big advantage in this respect as they allow scientists to design their
own experiments.
A number of investigations that would validate some results of this thesis could not be
carried out due to lack of time. These include the following:
• Immunohistochemical staining of melanoma samples. S-100 antibodies should
preferentially stain A375SM dense areas validating intra-epidermal clusters and
surface-spread tumour layers.
• PAS staining of melanoma tissues would validate glycogen accumulation in tissue
surrounding tumour-dense areas. Further to this, it might be of interest to quan-
tify glycogen using the 481 cm-1 peak. This might then be compared to wound
healing models to measure how similar the epithelial response is.
• RS on melanoma models fixed at different time points to study progression. This
might reveal spectral features that switch on or off during early and late stages
of growth.
• It is suggested that changes to the microenvironment may direct ini-
tial transformation and promote progression and invasion following
transformation [Bissell and Radisky 2001, Tlsty and Coussens 2006].
(Chapter 6). It would therefore be of interest to also look at benign or precan-
cerous nevi (especially if the samples are known to have progressed onto cancer)
to see if any of the features identified switch on at any particular point.
• We have not claimed any of the findings in Chapter 6 to be melanoma specific.
These need to be validated first on patient biopsies. This could include different
subtypes but should include benign melanocytic nevi to see if any of the features
hold true for melanoma but not for benign nevi.
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• Addition of a full spectrum of skin pathologies is also likely to improve inter-
pretation. This is important on two fronts: (i) For comparing pathologies such
as psoriasis or other inflammatory diseases that are known to show similar spec-
tral differences with melanoma compared to normal skin. This may help in un-
derstanding stromal response (rate, triggers, mechanism) in melanoma. (ii) To
compare pathologies that are commonly mistaken for melanoma. In literature,
predictions of tissue state using only Raman data are shown to be typically >85%
accurate in data sets that contain up to five pathologies such as melanoma, BCC,
SK. Addition of more is likely to cause sensitivity and specificity to drop but as
long as the separation keeps for benign versus malignant states, this can lend
itself to screening very well.
• Tracking identified spectral features after drug treatment of melanoma models.
And on a final note, the multidisciplinary nature of these kinds of studies should be
considered in future work. This type of project spans areas of spectroscopy, tissue cul-
ture, immunohistochemistry, cancer biology and chemometrics. Working teams should
reflect this and include a collaboration between clinicians, pathologists and scientists
of different fields.
Chapter 8
Appendix
8.1 Melanoma statistics
Geographic
region
Cancer type Incidence per
year (2012)
Mortality per
year (2012)
World Commonest cancer: Breast 1671149 521907
Melanoma (15th most common) 111481 24098
Europe Commonest cancer: Breast 494076 142979
Melanoma (8th most common) 55011 10785
UK Commonest cancer: Breast 52399 11679
Melanoma( 5th most common) 7545 950
Table 8.1: Incidence and mortality from commonest cancer type and melanoma for
women (recreated from [Globocan 2012]).
Geographic
region
Cancer type Incidence per
year (2012)
Mortality per
year (2012)
World Commonest cancer: Lung 1241601 1098702
Melanoma (16th most common) 120649 31390
Europe Commonest cancer: Prostate 419915 101419
Melanoma (16th most common) 49181 12723
UK Commonest cancer: Prostate 45406 10595
Melanoma (4th most common) 6900 1245
Table 8.2: Incidence and mortality from commonest cancer type and melanoma for
men (recreated from [Globocan 2012]).
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Figure 8.1: Age specific incidence rates of melanoma in the UK [CancerResearch 2011].
The greatest increase is seen in the age group 60-79 with a gender averaged increase of
546%.
Figure 8.2: Age and gender specific incidence rates of melanoma in the UK (recreated
from [CancerResearch 2011]). While the total number of diagnosed melanoma cases
are similar for males and females, there is a high percentage of women under 50, and
men over 60 that are being diagnosed.
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Table 8.3: Melanoma subtypes as listed by WHO [LeBoit et al. 2006].
Ten recognised subtypes of melanoma
Lentigo Maligna Melanoma
Superficial Spreading Melanoma
Nodular Melanoma
Acral Lentiginous Melanoma
Desmoplastic Melanoma
Melanoma arising from blue naevus
Melanoma arising in giant congenital naevi
Childhood Melanoma
Naevoid Melanoma
Persistent Melanoma
Table 8.4: Example markers of melanoma (from [LeBoit et al. 2006, Larson, Konat,
and Alani 2009]).
Marker Type
Melan-A Differentiation
S-100 Differentiation
TRP-1 Differentiation
Cyclin A and B1 Progression (upregulated during proliferative state)
p16 Progression (downregulated in proliferative state)
E-Cadherin Progression (downregulated, independent marker for
metastasis)
MMP-1, 2 and 9 Progression (upregulated)
MAP2 Differentiation (independent prognostic marker of
metastatic recurrence)
CHAPTER 8. APPENDIX 118
8.2 Melanoma classification
TNM and AJCC systems are used to classify melanoma. The systems enable clinicians
to estimate a patient’s prognosis and decide on treatment. It also allows therapeutic
responsiveness to be evaluated post-treatment and for comparisons to be made between
different centres. The systems supersede the morphological subtype classification.
TNM system is presented in Table 8.5. Each letter of the system reflects one of three
ways cancer spreads. T - extent of invasion into surrounding Tissue. N - extent of
invasion into lymph Nodes. M - extent of Metastasis through blood. A number is
then added to each letter to describe extent of invasion. Overall, the system presents
an evaluation of: the size of the primary tumour (T), the degree of regional spread (N)
and the range of distant metastasis (M).
After TNM classification, the evolutionary level of the disease is described by the AJCC
system. This system allocates a stage from 0 to IV depending on invasive capacity of
the tumour, with 0 being defined as melanoma in situ, and IV as developed distant
metastasis. TNM classifications corresponding to AJCC stages are presented in Table
8.6.
Table 8.5: TNM classification system for melanoma with corresponding AJCC stage
(recreated from [Edge and Compton 2010]).
STAGE TNM CLASSIFICATION
STAGE 0 Tis, N0, M0
STAGE IA T1a, N0, M0
STAGE IB T1b or T2a, N0, M0
STAGE IIA T2b or T3a, N0, M0
STAGE IIB T3b or T4a, N0, M0
STAGE IIC T4b, N0, M0
STAGE IIIA T1a to T4a, N1a or N2a, M0
STAGE IIIB T1b to T4b, N1a or N2a, M0
T1a to T4a, N1b or N2b, M0
T1a to T4a, N2c, M0
STAGE IIIC T1b to T4b, N1b or N2b, M0
T1b to T4b, N2c, M0
STAGE IV Any T, any N, M1(a,b or c)
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Table 8.6: AJCC system for melanoma with corresponding levels of invasion (recreated
from [Edge and Compton 2010]).
Stage Primary tumour (T) Lymph nodes (N) Metastases (M)
Stage IA <1mm, no ulceration,
mitoses <1 mm-2
Stage IB <1mm, with ulceration
or mitoses 1 mm-2
Stage IIA 1.01-2mm, with ulcera-
tion
2.01-4mm, no ulceration
Stage IIB 2.01-4mm, with ulcera-
tion
>4mm, no ulceration
Stage IIC >4mm, with ulceration
Stage IIIA Any Breslow thickness,
no ulceration
Micrometastases, 1-3
nodes
Stage IIIB Any Breslow thickness,
with ulceration
Micrometastases, 1-3
nodes
Any Breslow thickness,
no ulceration
1-3 palpable
metastatic nodes
Any Breslow thickness,
no ulceration
No nodes, but in-
transit or satellite
metastasis(es)
Stage IIIC Any Breslow thickness,
with ulceration
Up to three palpable
lymph nodes
Any Breslow thickness,
with or without ulcera-
tion
Four or more nodes
or matted nodes or
in-transit disease +
lymph nodes
Any Breslow thickness,
with ulceration
No nodes, but in-
transit or satellite
metastasis(es)
Stage IV, M1a Skin, subcutaneous or
distant nodal disease
Stage IV, M1b Lung metastases
Stage IV, M1c All other sites or any
other sites of metas-
tases with raised lac-
tate dehydrogenase
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8.3 Cell and Tissue culture consumables
Table 8.7: List of cell and tissue culture consumables and their suppliers.
Material Supplier
Trypsin Sigma Aldrich, UK
Fetal calf serum (FCS) Sigma Aldrich, UK
Dimethyl sulphoxide (DMSO) Sigma Aldrich, UK
Dulbeccos modified eagle’s medium (DMEM) Biosera, UK
Ham’s F12 medium Labtech International,
UK
Epidermal growth factor (EGF) Sigma Aldrich, UK
Hydrocortisone Sigma Aldrich, UK
Adenine Sigma Aldrich, UK
Transferrin Sigma Aldrich, UK
Insulin Sigma Aldrich, UK
Glutamine Sigma Aldrich, UK
Tri-iodothyramine Sigma Aldrich, UK
Amphotericin B Sigma Aldrich, UK
Penicillin/Streptomycin Sigma Aldrich, UK
Cholera toxin Sigma Aldrich, UK
Difco trypsin Difco Labs, USA
Collagenase A Sigma Aldrich, UK
Eagle’s modified essnetial medium (EMEM) Biosera, UK
Fungizone Sigma Aldrich, UK
Calcium fluoride slides and windows Crystran, UK
Magnesium fluoride slides Crystran, UK
Quartz slides UCG Optics, UK
Sapphire and Calcium fluoride cover slips UCG Optics, UK
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8.4 Tissue culture protocols
Table 8.8: Schedule for the Leica TP1020 tissue processor. 18 hours in total.
Step Time
70% IMS (x2) 1 hour each
80% IMS 1.5 hour
85% IMS 1.5 hour
90% IMS 1.5 hour
95% IMS 1.5 hour
100%IMS (x2) 1.5 hour each
Xylene (x2) 1.5 hour each
Paraffin wax (x2) 2 hour each
Table 8.9: Schedule for H&E staining of wax and cryo embedded sections.
Step Time
Wax embedded
Xylene (x2) 3 min each
100% IMS 1 min
70% IMS 30 sec
Distilled water 1 min
Haematoxylin 1.5 min
Tap water 4 min
Eosin 5 min
Tap water (x2) dunk each
70% IMS dunk
100% IMS 30 sec
Xylene dunk
Cryo embedded
PBS (x10) <30 sec
Haemotoxylin 1.5 min
Water rinse 4 min
Eosin 3 min
Water rinse (x2) dunk
70% alcohol dunk
90% alcohol dunk
CHAPTER 8. APPENDIX 122
CHAPTER 8. APPENDIX 123
8.5 PCA of A375SM models
(a) (b)
(c)
Figure 8.3: PCA results for category 1 areas of A375SM models over the spectral
range 1800-450 cm-1. Spectral features associated with Phe, Trp, Tyr, Glyc, lipids
and Amides are powering the separation between clustering and surrounding regions.
Data points are colour coded: Blue=cluster, Green=surrounding tissue, Red=dermis
(Chapter 6).
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(a) (b)
(c)
Figure 8.4: PCA results for category 1 areas of A375SM models over the spectral range
1800-450 cm-1. Spectral features associated with the same areas as for Figure 8.3 are
again powering separation between cluster and surrounding regions. Data collection
points on the white light image are seen in (a). Data points in PCA correspond to
Blue=cluster, Green=surrounding tissue, Red=dermis (Chapter 6).
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8.6 PCA of C8161 models
(a)
(b)
Figure 8.5: PCA results of C8161 models over various category areas and the range
1800-450 cm-1. The scores plot contains spectra from two large sample areas. Loadings
plot (b) corresponds to scores plot (a). Data points are labelled according to the sample
area they were collected from. Blue=cluster, DarkBlue=surface, Green=surrounding
tissue, Red=dermis. Features separating surface layers are discussed in Chapter 6.
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(a)
(b)
Figure 8.6: PCA results of C8161 models over various category areas and the range
1800-450 cm-1. The scores plot contains spectra from two large sample areas. Loadings
plot (b) corresponds to scores plot (a). Data points are labelled according to the sample
area they were collected from. Blue=cluster, DarkBlue=surface, Green=surrounding
tissue, Red=dermis. Features separating surface layers are discussed in Chapter 6.
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